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Abstract
Wenker, Ian Christopher. M.S., Department of Physiology and Biophysics, Wright State
University, 2009. The Role of Nucleotide Signaling in the Regulation of ICl,swell in Human
1321N1 Astrocytoma Cells

Swollen cells expel osmolytes to decrease volume in a process referred to as
Regulatory Volume Decrease, or RVD. The plasma membrane current ICl,swell is
ubiquitously expressed in mammalian cells and contributes significantly to RVD. In a
variety of cell types, activation of ICl,swell is enhanced by nucleotide signaling. In this
study, we used human astrocytoma cells to examine whether nucleotide signaling is
necessary or sufficient for ICl,swell activation. Three clones of the 1321N1 human
astrocytoma cell line were used for voltage clamp recordings. One clone was transfected
with P2Y1 receptors, another with P2Y2 receptors and a third was devoid of any P2Y
receptors (Parental). In physiological solutions, hyposmotic exposure (HOE) caused
increased membrane conductance in each cell line. HOE also depolarized the reversal
potential in P2Y1 and P2Y2, but not in Parental, cell lines. In solutions containing no
permeable cations, HOE activated ICl,swell in morphologically round cells of each cell line
and in morphologically flat P2Y1 and P2Y2 cells. However, morphologically flat
Parental cells did not demonstrate HOE-induced ICl,swell activity. Exogenous ATP
activated a chloride current with an electrophysiological profile different from ICl,swell. I
conclude that P2Y nucleotide signaling may play a role in gating ICl,swell, but is not
necessary for its activation. P2Y receptor stimulation is sufficient to activate a chloride
current, but whether the response is mediated by P2Y1 or P2Y2 receptors requires further
investigation.
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I. Background and Literature Review

A. Glial Cells
Introduction
Glial cells were discovered during the mid-19th century. This was not too long
after Scwhann and Schleiden theorized that all living matter was composed of cells in
1839 (Kimelberg 2004). It was Rudolf Virchow who first coined the term neuroglia,
meaning “neural-cement,” in 1856 (Ndubaku & de Bellard 2008). Virchow’s
histochemical stains illustrated clear distinctions between neurons and glia but were
unable to delineate between the different subtypes of glia. Using the black chrome-silver
reaction Camillo Golgi was the first to distinguish radial glia from other glia and neurons
in 1895 (Kimelberg 2004). Ramon y Cajal was the first to use the term astrocyte to
describe the fibrous and protoplasmic glial subset (Somjen 1988). He identified
astrocytes using gold sublimate, which stained for what is known today as glial fibrillary
acidic protein, GFAP. In 1920 Cajal’s student del Rio Hortega was able to distinguish
oligodendrondrocytes and microglia from the other two glial subsets (Somjen 1988).
Neuroglia have since been split into two broader classes of macroglia and
microglia, the latter being the primary immune cell in the brain. Macroglia in the
peripheral nervous system (PNS) consist of Schwann cells and satellite cells. Schwann
cells’ main role is that of axon myelination (Ndubaka & de Bellard 2008). Their long end
feet wrap around myelinated fibers of the PNS resulting in faster signal transduction.
Satellite cells line the exterior portion of the PNS and regulate the exterior chemical
environment (Topilko 2007). Macroglia in the CNS consist of four distinct types;
oligodendrocytes, radial glia, ependymal cells and astrocytes. Similar to Schwann cells,
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oligodendrocytes have small somas and large end feet that are responsible for axon
myelination (Ndubaka & de Bellard 2008). Radial glia have many roles in the CNS. In
the developing brain, radial glia act as scaffolding for immature neuron migration
(Kimelberg 2004). In the cerebellum and retina, radial glia are involved in synaptic
plasticity and bidirectional communication with neurons, respectively. Ependymal cells
create the walls of the ventricles (Meiniel 2007). Astrocytes are the most numerous cells
in the CNS and perform many functions as discussed below.

Astrocyte Physiology
Astrocytes account for approximately 20-30% of brain cells in the mature CNS
and are crucial for maintaining relative homeostasis (Kimelberg 2004, Hertz & Zielke
2004). In the microenvironment astrocytes mediate neurotransmitter and ionic
homeostasis, synaptic formation, neuronal excitability and migration, detoxification and
maintenance of the blood brain barrier (Markiewicz & Lukomska 2006). Proper astrocyte
function is very important for the function of the brain as a whole. Astrocytes are known
to secrete a wide variety of neurotrophic factors, such as nerve growth factor, NGF, and
brain-derived neurotrophic factor BDNF (Villegas, Poletta & Carri 2003). Astrocytes
regulate the extracellular space near synapses after high neuronal output by absorbing
potassium (Leis, Bekar & Walz 2005, Olsen, Campbell & Sontheimer 2007) as well as
neurotransmitters (Hertz & Zielke 2004).
The electrophysiology of astrocytes is quite uniform. Sontheimer and colleagues
recorded electrically from astrocytes in three different regions of the rat brain; the
hippocampus, cerebral cortex and spinal cord. Each cell type had very similar
2

electrophysiological properties (Bordey & Sontheimer 2000). All cells expressed
transient KA currents, rectifying KDR currents and inward Na+ currents in all three regions
at all stages of development. Older animals also exhibited KIR in all three regions.
Sontheimer and colleagues also recorded from Bergmann glia in the cerebellum that
appeared not to have KDR or KA currents. After employing leak subtraction, both KDR and
KA currents were also found in these cells.
Originally astrocytes, as well as other glial cells, were thought to simply provide
neurons with structural support, but in more recent decades it has become clear that
astrocytes also are directly involved in synaptic communication. They are able to
stabilize as well as modulate synaptic activity (Haydon 2000). Astrocytes express many
neurotransmitter receptors that, when activated, initiate calcium signaling (Schipke &
Kettenman 2002, Villegas et al. 2003). These calcium waves spread between adjacent
astrocytes via gap junctions and nucleotide signaling (Inoue, Schuichi & Tsuda 2007),
which can then trigger release of ATP and glutamate; the main mediators of neuron-glia
cross-talk (Villegas et al. 2003). Astrocytes also have been found to communicate with
microglia and capillaries (Inoue et al. 2007).

Astrocyte Pathophysiology
Astrocytes participate, along with microglia, in the general immune response of
the brain by secreting pro-inflammatory cytokines Tumor Growth Factor-1, Tumor
Necrosis Factor-, and Interleukins 1 and 6 (Dong 2001). While a controlled
inflammatory response can be beneficial under many circumstances, it has been observed
that in pathological states these pro-inflammatory mediators can lead to neuronal damage
3

and cell death. The neurotoxic effects of TNF- (Kielen & Drew 205) and IL-1 (John,
Lee & Brosnan 2003) have both been illustrated in vitro. The damage caused by
inflammation is thought to contribute to several disease states such as Alzheimer’s
disease, Parkinson’s disease, Huntington’s disease, amyotrophic lateral sclerosis (ALS)
and multiple sclerosis (MS) (Markiewicz & Lukomska 2006).
Rapid swelling of astrocytes is observed after numerous traumatic brain injuries,
including stroke (Barron et al. 1988, Kimelberg et al. 2000, Mongin & Kimelberg 2005,
Somjen 2004). Decreased extracellular space (ECS) is also observed after the traumatic
event (Van Harreveld 1972). While other factors, such as dendritic swelling, could
contribute to the decrease in ECS, it would seem that the swelling of astrocytes must play
a significant role (Mongin & Kimelberg 2005). After 30 minutes of a focal ischemia
astrocytes’ intermediate metabolism is compromised leading to a decreased buffering
capacity for extracellular potassium and glutamate (Hagberg et al. 2001). The
combination of decreased ECS and astrocyte buffering capacity causes an increase of
harmful substances in the ECS, including excitatory amino acids (EAA), reactive oxygen
species (ROS), prostanoids and nitric oxide (NO) (Sykova & Chvatal 2000). It is not
surprising to find that edema is a common cause of delayed death after stroke and other
brain injury (Markiewicz & Lukomska 2006). The mechanisms of cell swelling and
recovery in the brain are not fully understood. Future research will address some of these
uncertainties and potentially lead to better treatment of patients with brain edema.
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B. Nucleotide Signaling
Adenosine Tri-phosphate
Adenosine tri-phosphate, ATP, a purine nucleotide, plays important roles in many
different areas of the life sciences. Most notably ATP is the “molecular currency” of
energy transfer within a cell. Much of the study of biochemistry is concerned with its
synthesis and metabolism. ATP is generated during glycolysis, photosynthesis and
cellular respiration and the energy stored in the three phosphate bonds can be used for
many cellular functions. Transmembrane pumps, such as the Na-K-ATPase, use the
energy stored in the phosphate bonds of ATP to move molecules against their
electrochemical gradient. ATP is also important biologically in aspects other than as a
transducer of chemical potential energy. Cellular signaling pathways utilize ATP. In
intracellular signal transduction pathways, ATP is used as a substrate by kinases that
phosphorylate proteins and lipids, and adenylate cyclase that produces the second
messenger molecule, cyclic AMP. More recently ATP has been found to be involved in
intercellular signaling, acting in autocrine, paracrine and neurocrine mechanisms on
extracellular nucleotide receptors (Burnstock 1972).
Perhaps due to the fact that ATP is such an important molecule for cell
metabolism it was difficult for the scientific community to accept that it was involved in
intercellular signaling. The first observation that ATP can act extracellularly occurred
during experiments on cardiac tissue in 1929 (Drury & Szent-Györgyi 1929). Later it was
found to act in the intestine (Gillespie 1934) and parts of the spinal cord (Buchthal,
Engbaek, Sten-Knudsen & Thomasen 1947), as well as other areas. Exogenous ATP
causes electrophysiological changes in certain brain regions (Galindo 1967) and acts as
5

an antagonist to certain anesthetics (Kuperman, Okamoto, Beyer & Volpert 1964). In
1970 Geoffrey Burnstock postulated that ATP is used for specific intercellular signaling
(Burnstock 1970). He discovered nerves in the autonomic nervous system innervating the
gut and bladder that utilized ATP as their neurotransmitter. Since then ATP has been
described as a neurotransmitter in the autonomic, central and nociceptive nervous
systems and is a cotransmitter in many other regions (see Burnstock 2007 for review).

Pericellular ATP
Early studies of ATP release usually involved bioluminescent measurements of
the bathing solution of the cells subjected to mechanical stress (Schwiebert & Zsembery
2003). This technique resulted in calculated concentrations of ATP in the nanomolar
range, well below the micromolar concentrations needed to stimulate most nucleotide
receptors (Bours, Swennen, Virgilio, Cronstein & Danelie 2006). Using a different
technique, Dubyak and colleagues discovered that ATP concentrations in the area near
the cell membrane, termed the pericellular space, are several orders of magnitude higher
than that of the bulk bath solution (Joseph, Buchakjian & Dubyak 2003). The technique
used membrane attached protein-A luciferase to analyze ATP release in the pericellular
space. Micromolar amounts of ATP were found to accumulate in the pericellular space of
human astrocytoma cells (Joseph et al. 2003) and primary airway epithelial cells (Okada,
Nicholas, Kreda, Lazarowski & Boucher 2006) when stimulated by Ca2+ mobilizing
enzymes or hypotonic stress, respectively.
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ATP Release during Cell Swelling
It has been shown in many cell types that ATP is released during cellular swelling
(Sabirov, Dutta & Okada 2001, Wehner, Olsen, Tinel, Kinne-Saffran & Kinne 2003).
When using a technique that measures ATP concentration in close proximity to the cell
membrane, ATP concentrations increase to 10s of µM when cells are exposed to
hyposmotic media (Dubyak & El-Moatassum 1993). This concentration of ATP is large
enough to stimulate the P2Y sub-type of nucleotide receptors (Dezaki, Tsumura, Maeno,
Okada 2000). The effects of ATP release on RVD were studied by exposing human
intestine 407 cells to hyposmotic media and measuring cell volume over a time course of
several minutes (Dezaki 2000). In control experiments the cells exhibited RVD. In
separate experiments, cells were exposed to either suramin, a broad P2 receptor blocker,
apyrase, an ATP-hydrolyzing enzyme, ATP or UTP, along with the hyposmotic media.
Both suramin and apyrase blunted the RVD effect while the addition of micromolar
amounts of ATP and UTP caused an increase in the amount of RVD. This suggests that
the release of ATP during cell swelling plays a significant role in the mechanism of RVD.
Similar effects of suramin and apyrase on RVD responses have been found in other cell
types (Wang, Roman, Lidofsky & Fritz 1996, Roman et al. 1997, Roman, Feranchak,
Salter, Wang & Fritz 1999).
The mechanism for ATP release during cell swelling has been a highly debated
subject for more than a decade. Early proposed mechanisms for ATP release included the
cystic fibrosis transmembrane conductance regulator, CFTR, (Schwiebert et al. 1995) and
the volume-regulated anion channel, VRAC (Hisadome et al. 2002). Evidence against
both CFTR and VRAC as ATP conductive pathways has been demonstrated in human
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intestine 407 cells (Hazama et al. 1999) as well as mouse mammary C127 cells (Hazama
et al. 2000). Although these two specific anion channels are unlikely to mediate ATP
release, other evidence suggests an anion channel is likely. In recent studies (Sabirov et
al. 2001, Dutta, Okada & Sabirov 2002) a maxi-conductance, volume-activated anion
channel has been found to facilitate swelling induced ATP release. A similar maxi-anion
channel in kidney macula densa cells conducts ATP during exposure to increased
extracellular NaCl levels (Bell et al. 2003). Another proposed mechanism of release is
through connexin 43 hemichannels. C6 glioma cells transfected with connexin 43
demonstrated ATP release and calcium signaling upon mechanical stimulation, while the
parental cells lacking connexin 43 were unable to do so (Stout, Costantin, Naus & Charls
2002, Kang et al. 2008).
The main effect of autocrine ATP signaling appears to involve calcium signaling.
In human intestine 407 cells, activation of P2Y receptors by micromolar amounts of ATP
and UTP increases intracellular Ca2+ (Dezaki et al. 2000). Hyposmotic exposure also
increases intracellular Ca2+ and exogenous ATP or UTP augments this response. In these
cells the increase in intracellular Ca2+ is due to release from intracellular stores as well as
from influx via Ca2+-permeable cation channels (Dezaki et al. 2000, Hafting, Haug,
Ellefsen & Sand 2006). These increases in intracellular Ca2+ activate the intermediateconductance K+ and IK channels in Intestine 407 cells (Wang, Morishima & Okada 2003)
and large-conductance K+, BK, channels in Vero cells (Hafting et al. 2006). Although
increased extracelluar ATP was not able to activate chloride currents in Intestine 407
cells (Dezaki et al. 2000), more recent research in rat primary cultured astrocytes
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indicates that perhaps ATP can activate VRACs via P2Y2 signaling (Darby, Kuzmiski,
Panenka, Feighan & Macvicar 2003).

Nucleotide-converting Ecto-enzymes
Another factor in the nucleotide signaling cascade is the presence of nucleotide
converting enzymes in the extracellular space. When ATP is accumulated in the
pericellular space it comes into contact with many nucleotide-converting ecto-enzymes
that convert ATP to ADP, AMP, adenosine, inosine and hypoxanthine. Converting ectoenzyme families include ecto-nucleoside triphosphate diphosphohydrolase (E-NTDPase)
(Zimmermann 1996), which dephosphorylates ATP and ADP, ecto-nucleotide
pyrophosphatase/phosphodiesterase (E-NPP) (Stefan 2005), which can hydrolyze
pyrophosphate and phosphodiester bonds in many molecules including nucleotides, and
ecto-5’-nucleotidase (Zimmermann 1992), which dephosphorylates AMP to adenosine.
Adenosine can then be further broken down by adenosine deaminase (ADA) and purine
nucleoside phophorylase (PNP) or be transported, by active or facilitated diffusion, back
into the cell (Thorn & Jarvis 1996). Most cell types express one or more of these
enzymes on the extracellular side of their membrane. Thus ATP and other nucleotide
concentrations are determined not only by the amount released but also by the metabolic
rate of these ecto-enzymes (for review see Yegutkin 2008).

Nucleotide Receptor Subtypes
The membrane receptors whose ligands are purines and pyrimidines are
commonly referred to as nucleotide receptors. There are at least three different families
9

of nucleotide receptors; P1 (also referred to as adenosine receptors), P2X and P2Y
receptors. Nucleotide receptors have been found to be located in many regions of the
body and function in an equally wide array of cellular processes.
P1 receptors are G-protein coupled receptors. There are four P1 receptor subtypes;
A1, A2A, A2B and A3, which all respond to adenosine as their endogenous agonist.
When A1 and A3 receptors are activated they stimulate Gs, which causes an increase in
cAMP. Activation of A2A and A2B receptors stimulates Gi, which causes a decrease in
cAMP (Burnstock 2007). P1 receptor activation causes decreased heart rate, coronary
vasodilatation and A2B, in combination with neutrin-1, is involved with axon elongation
in neurons (see Fredholm, Ijzerman, Jacobson & Klotz 2001 for review of P1 receptors).
P2X receptors are ionotropic with two transmembrane domains. There are seven
cloned P2X subtypes; P2X1-7, which all respond to ATP as their endogenous agonist.
P2X receptors act as cation channels and upon activation by ATP, allow the flow of
sodium, potassium and in some cases calcium. This causes depolarization of the cell
membrane, which in turn activates Ca2+ channels (Dubyak & El-Moatassum 1993).
P2X1-6 are all very similar in structure while P2X7 has an elongated intracellular peptide
sequence on the carboxy end. When exposed to ATP it initially functions as the other
P2X receptors, however if the ATP exposure is prolonged its pore enlarges and larger
molecules can flow through. It is mainly expressed in immune cells and glia, and seems
to allow the release of proinflamatory cytokines (Burnstock 2008). P2X receptors have
been located in neurons, glia, bone, muscle, endothelium and hematopoietic cells
(Burnstock 2004, North 2002), and have functions including fast synaptic transmission
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(Bardoni 1997), neurotransmitter release (Khakh & Henderson 1998) and pain signaling
(Cockayne et al. 2000).
P2Y receptors are G-coupled with seven transmembrane spanning domains. There
are eight P2Y receptor subtypes that have been cloned; P2Y1, P2Y2, P2Y4, P2Y6 and
P2Y11 through P2Y14 (Burnstock 2007, Erb, Weaver, Seye & Weisman 2006). P2Y
receptors respond to a more varied array of endogenous agonists, including ATP, ADP
and even UTP. The strength of response to these agonists varies by receptor subtype,
which is sometimes used to identify receptor subtype. For instance, if a cell exhibits a
physiological response to ATP and UTP, but not ADP then the responsible receptor is
either P2Y2 or P2Y4. G-proteins utilized by P2Y receptors are Gi, Go, Gs, Gq/G11, Gi,
G12 and Gi/Go (Erb et al. 2006). Some P2Y receptor subtypes have specific G-proteins
they associate with, but many can associate with multiple. The P2Y2 receptor can
activate Go, Gq/G11 and G12 (Erb et al. 2006). Stimulation of these G-proteins by
recombinant P2Y receptors can either activate phospholipase C (PLC) or adenylate
cyclase, causing intracellular Ca2+ release or changes in cAMP levels, respectively
(Burnstock 2007). P2Y signaling is responsible for numerous physiological responses
(Burnstock 2007). P2Y receptors are thought to play a role in the activation of ion
channels, including the volume-regulated anion channel (Darby et al. 2003) and of Ntype Ca2+ channels (Abbracchio et al. 2006). P2Y receptor expression has been shown to
influence cell proliferation in a number of cell types (Bagchi et al. 2005) and is
upregulated in response to tissue injury (Ahn, Camden, Schrader, Redman & Turner
2000, Schafer, Sedehizade, Welte & Reiser 2003, Tu et al. 2000). In the brain, nucleotide
signaling seems to be neuroprotective. The P2Y2 receptor subtype expression has been
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found to increase cell survival rates in cultured astrocytes subjected to trauma (Chorna et
al. 2004).
Although specific agonists exist for many of the nucleotide receptor subtypes, the
use of pharmacology to identify subtype activation is difficult. There is much overlap in
the agonist profiles of many nucleotide receptors, and often specificity is very
concentration dependent (Burnstock 2007). Similarly, agonists for nucleotide receptors
lack specificity. In this study genetically modified cells are used to overcome this
obstacle. Cells transfected with particular P2Y receptors are utilized to ensure
physiological responses can be attributed to specific receptor subtypes.

C. Cell Swelling and Regulatory Volume Decrease
Cellular Swelling
The concept of cell volume regulation is so fundamental that many first learn of it
in high school biology. Cells collected from a student’s mouth, or perhaps a nearby pond,
are studied under a microscope while tap water replaces the normal liquid environment.
The cells viewed in the microscope increase in size and eventually burst. However, cells
exposed to a solution of one-half tap water and one-half liquid from natural environment
will initially swell, but eventually shrink back to their original size. This second outcome
is reproducible in almost all animal cells (for one exception see De Smet, Oike,
Droogmans, Van Driessche, & Nilius 1994).
Cells also are subject to changes in volume due to a number of physiological
situations. Renal cells must respond to osmotic changes that occur during antidiuresis and
diuresis (Beck 1988). Pathological situations in the brain, such as ischemia and traumatic
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brain injury (TBI) often present with cellular swelling (Barron et al. 1988, Kimelberg et
al. 2000, Somjen 2002). Causes for swelling can even be cell specific. For instance,
astrocytes swell when exposed to millimolar levels of glutamate (Bender, Schousboe,
Reichelt & Norneberg 1998, Koyama, Baba & Iwata 1991). Transepithelial transport of
solutes into cells can cause cell swelling even when the extracellular environment
remains isotonic (McCarty & O’Neil 1991).

Water Flux
Most biological matter is water, which flows easily through the plasma membrane
of almost all mammalian cells. Thus, a cell swells because it has taken on more water.
Likewise, when a cell loses water it shrinks. The relation of water flux through a semipermeable membrane can be described by the equation:

Jv = Lp (∆p – ∆π)

where Jv is the flux of water, Lp is the hydraulic conductivity of the cell’s membrane, ∆p
is the change in hydrostatic pressure and ∆π is the change in osmotic pressure. While
Lp, ∆p and ∆π all affect the resulting flux in water, and hence the change in cell volume,
in a physiological setting ∆π is the variable with the most potential to change.
Most animal cells’ membranes are very permeable to water as compared to other
molecules, meaning the Lp is high. This is because water is small, unlike larger organic
molecules, and is uncharged, unlike impermeable ions. The Lp is increased in many
membranes by the presence of aquaporins, which create pores in the cell membrane and
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facilitate the movement of water (Agre, Brown & Nielson 1995, Echevarria, Windhager,
Tate & Frindt 1994, Fushimi et al. 1993, Hill 1994). The expression of aquaporins also
can be regulated and thus effect the ability of water to flux across a cell membrane. In the
vast majority of circumstances water easily passes through biological membranes and
thus any change in osmolarity will be followed by the obligatory water flux.
Hydrostatic pressure, ∆p, is the physical pressure exerted by water, generally
generated by gravity or some other physical force, such as hydrostatic pressure that
moves plasma through the capillary walls. A cell membrane can only withstand a
hydrostatic pressure gradient of 2 kPa (Guharay 1984). Thermodynamically this is equal
to an osmotic gradient difference of 1 mOsm. Considering isotonic conditions are about
290 mOsm, we can calculate that a decrease in extracellular osmolarity of 1 mOsm would
result in the cell swelling by only 0.35%. When an intact cytoskeleton is present, the
membrane can withstand greater hydrostatic gradients (Jacobson 1983, Mills 1987). Even
so, ∆p is only able to play a minimal role in flux of water in or out of an animal cell.
∆π is the difference in osmotic pressure between two solutions separated by a
semi-permeable membrane. Each solution exerts its own osmotic pressure, and for dilute
solutions π can be described by the equation:

π=i·M·R·T

where i is the van’t Hoff factor, M is the molarity of the solution, R is the gas constant
and T is the absolute temperature. The van’t Hoff factor, named after the equation’s
creator, is the number of osmotically effective moles of solute actually in solution per
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mole of solid solute added. In a biological system both i and R are constant. While
temperature can change, it will generally be the same on either side of the membrane,
causing no effect to the ∆π. Thus M, the molarity of a solution is the main determinant
of a solution’s osmotic pressure. As discussed above, any difference in osmotic pressure
will cause water flux and thus changes in cell volume. If the extracellular solution is
isotonic with respect to the intracellular solution, the ∆π will equal zero, there will be no
flux of water and consequently cell volume will remain unchanged.

Steady-State Volume Regulation
Cell volume regulation is a dynamic process. Even when a cell is under isosmotic
conditions it must still actively regulate its volume to keep from swelling. Cells contain a
cache of various membrane impermeable molecules that increase the intracellular
osmolarity. Without regulation, these osmolytes would cause the cell to swell. To
compensate for this, most cells utilize a process that is referred to as the Double Donnan
Hypothesis (Leaf 1956, MacKnight & Leaf 1988). The cell employs the Na+/K+ ATPase
to actively pump sodium ions out of the cell and thus decrease the concentration of
intracellular sodium.

This decrease in sodium concentration helps to balance the

relatively high concentration of organic osmolytes in the cell. It has been shown that
blocking the Na+/K+ ATPase with ouabain causes cell swelling (Lang, Messner & Wang
1983, MacKnight & Leaf 1988). The intracellular fluid of the cell is initially isosmotic
with respect to the extracellular fluid because sodium levels are kept low inside the cell,
but ouabain disables the cell’s mechanism for removing this sodium. As intracellular
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sodium increases so does the cell’s osmolarity. Thus, water will flux into the cell and it
will swell.

Cell Volume Regulation
Theoretically a cell will increase in volume proportionally to the ratio in
osmolarity between the extra and intracellular solutions. For example, a cell exposed to
an extracellular solution whose osmolarity is half that of the intracellular solution should
swell to twice its normal volume. However, cells do not behave as perfect osmometers.
One convincing theory proposes that some portion of the cytosol is osmotically inactive,
possibly due to many water molecules being bound to organic molecules, such as the
cytoskeleton (Lucke & McCutcheon 1932). Figure 1 illustrates this using a Boyle – van’t
Hoff Plot. In this figure about 31.8% of the rat hepatocyte cells’ intracellular fluid is
osmotically inactive.
Most animal cells have the capacity to regulate their volume. Some of the first
studies of cell volume regulation were performed in red blood cells. One of the more
notable studies used duck red blood cells to demonstrate active cell volume regulation in
anisotonic conditions (Kregenow 1977). A swollen cell actively decreases its volume by
a process referred to as Regulatory Volume Decrease, or RVD. Similarly, a shrunken cell
will increase its volume by a process referred to as Regulatory Volume Increase, or RVI.
Available organic and inorganic osmolytes can be either expelled, in the case of RVD, or
imported, in the case of RVI, to cause corresponding flux of water and thus return the cell
closer to its initial volume. While RVI plays an important role in many physiological
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Figure 1 Boyle – van’t Hoff plot of rat hepatocyte cell volumes at various
extracellular osmolarities. With all volume regulatory mechanisms blocked the passive
changes of rat hepatocyte volumes after 10 min exposure to hypertonicity (327, 360, 400,
and 450 mOsm/l) are a linear function of the reciprocal of extracellular osmolality. The
value of 3.33 is equivalent to 300 mOsm/l where cell volumes equal 100%. The intercept
of the regression line with the volume axis is equivalent to the “osmotically inactive
space” that amounts to 31.3% of total cell volume (adapted from Wehner and Tinel
2000).
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processes, the present study focuses on the mechanisms involved in the RVD of
osmotically swollen cells. (See Wehner et al. 2003 for Review)

Potassium – Chloride Cotransport
In human glioma cells it was found that 30-40% of cell RVD could be attributed
to osmolytes moved by KCl cotransport (Ernest, Weaver, Van Duyn & Sontheimer
2005). KCl cotransport, via the KCC (Potassium-Chloride Cotransporter) family, in
response to cell swelling has been observed in erythrocytes (Sachs & Martin 1993) as
well as many other cell types (Thornhill & Laris 1984, Perry & O’Neill 1993, Shen, Chou
& Ellory 2000, Orlando, Tobey, Wang, Abdulnour-Nakhoul & Orlando 2002, Lauf &
Adragna 2000). At present there are four isoforms in the KCC family, KCC1 through
KCC4. Research indicates that KCC1 (Mount et al. 1999, Su et al. 1999, Mercado, Song,
Vazquez, Mount & Gamba 2000, Lauf et al. 2001), KCC3 (Mount et al. 1999, Race et al.
1999) and KCC4 (Mercado et al. 2000) activate during cell swelling while KCC2 does
not (Payne 1997). KCCs have been shown to be stimulated in many different ways,
including oxidizing agents and low Mg2+ (Lauf & Adragna 2000, Jennings 1999). One
mechanism of activation for KCCs is dephosphorylation (Lauf and Adragna 2000,
Jennings & Schultz 1991, Kaji & Tsukitani 1991). Interestingly, phosphorylation is an
activator of NKCCs (sodium-potassium-chloride cotransporters) that are upregulated
during RVI. This has led to the proposal of a “phosphorylation – dephosphorylation”
mechanism to regulate cotransporters in response to cell volume change (Jennings &
Schultz 1991, Cossins 1991, Dunham, Klimczak & Logue 1993).
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Organic Osmolytes
While the inorganic ions mentioned above are capable mediators of RVD, their
efflux from the cell interior also can pose problems. Changes in ion concentrations inside
and outside the cell can affect the function of enzymes and proteins (Andrews, Maughan,
Nosek & Godt 1991, Yancey, Clark, Hand, Bowlus & Somero 1982). In the brain,
alterations of ion distribution also can affect neuronal excitability (Iwasa, Tasaki &
Gibbons 1980). Uncharged organic osmolyte release does not pose such problems and
are therefore considered more “compatible” to cell function. These observations have led
to the “compatible osmolyte” hypothesis, which explains why certain cells use organic
osmolytes, instead of ions, to achieve volume regulation. It is not surprising that cell
swelling induces the exit of certain organic osmolytes in many cell types (Yancey et al.
1982, Hoffman, Lambert & Simonsen 1988, Kinne, Czekay, Grunewald, Mooren &
Kinne-Saffran 1993, Burg 1995, Burg 1996, Junankar & Kirk 2000).
The amino acid taurine is a zwitterion that contributes to RVD in many cell lines,
such as Ehlich Ascites tumor cells (Hoffman et al. 1988), HeLa cells (Hall, Kirk, Potts,
Rae & Kirk 1996), C6 glioma cells (Jackson & Strange 1993) and astrocytes (Moran,
Maar & Pasantes-Morales 1994, Olson 1999). Taurine release is passive; meaning its
movement follows its electrochemical gradient (Sanchez, Pasantes-Morales, Lazaro &
Cereijido 1991, Goldstein, Davis-Amara & Musch 1996, Junankar & Kirk 2000) and is
inhibited by anion channel blockers (Roy & Malo 1992). This suggests that taurine is
released via an ion channel and not by a transporter. Other types of organic osmolytes are
also released during RVD. Studies performed in C6 glioma cells (Jackson & Strange
1993) and rat IMCD cells (Ruhfus, Bauernschmitt & Kinne 1998) demonstrate
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hyposmotically induced fluxes of myo-inositol. Sorbitol also has been shown to efflux
during RVD in C6 cells (Jackson & Strange 1993), rat IMCD cells (Grunewald 1989,
Ruhfus et al. 1998) and Hela cells (Hall et al. 1996).
Ion Channel Mediated RVD
Under certain circumstances, such as ischemia (Askenasy & Navon 1997), a cell may
encounter extracellular fluid that is significantly lower in osmolarity, and as a result,
experience an influx of water. The most efficient way for a cell to perform RVD is to
expel a fraction of the ions that are residing in the intracellular fluid. This will result in
osmotic water efflux thus maintaining relative volume homeostasis. The fastest way for
an ion to exit a cell is through a channel, as compared with cotransporter or pumps. Ions
move passively through channels down their electrochemical gradient. In many cells,
both chloride and potassium ions are accumulated against their electrochemical gradient
thus making them optimal choices to facilitate RVD. Most mechanisms of RVD include
the loss of both potassium and chloride. This coupling of ions for RVD is due in part to
their opposite charges. Suppose a cell responds to a hyposmotic challenge by increasing
membrane conductance for potassium, and thus causing potassium to flow out of the cell.
This increase in potassium conductance also will cause the membrane to hyperpolarize,
increasing the driving gradient for chloride and leading to chloride efflux. Similarly, an
increase in chloride conductance will lead to an increased potassium driving force. (for
reviews see Lang et al. 1998, Wehner et al. 2003).

Potassium Channels Involved in RVD
Many potassium channels have been directly or indirectly shown to become
activated during cell swelling. The BKCa channel, also referred to as the Maxi-K channel,
20

is activated during hyposmotic conditions. BKCa’s activation during swelling has been
shown in both primary and clonal kidney cultures (Dube, Parent & Suave 1990, Filipovic
& Sackin 1991, Kawahara, Ogawa & Suzuki 1991, Ling, Webster & Eaton 1992,
Schlatter 1993, Stoner & Morley 1995, Hirsch & Schlatter 1997, Hafting & Sand 2000).
BKCa channels are activated by micromolar concentrations of intracellular Ca2+ and
membrane depolarization (Vergara, Latorre, Marrion & Adelman 1998). They exhibit
large unitary conductances in the range of 100 to 250 pS and are inhibited by tetra-ethylammonium, TEA (Vergara 1998). BKCa channels are also activated in cloned kidney
cells by exogenous ATP (Hafting & Sand 2000, Hafting 2006).
IKCa channels have been shown to activate under hyposmostic conditions in T
lymphocytes (Khanna, Chang, Joiner, Kaczmarek & Schlichter 1999). IKCa channels are
so called because they exhibit an intermediate unitary conductance that ranges from 20 to
80 pS. The currents mediated by IKCa are slightly inwardly rectified and Ca2+ sensitive.
These experiments (Khanna et al. 1999) demonstrate hyposmotically induced
intermediate potassium conductances that were inwardly rectified and Ca2+ sensitive.
Also the conductances were inhibited by the selective IKCa channel blocker clotrimazole
(Jensen, Stroback, Olesen & Chritophersen 2001 for review).
Several other potassium channels exhibit conductances triggered by hyposmotic
exposure, suggesting they also play a role in RVD. Kv1.3, a voltage-activated delayedrectifier channel, is activated during cell swelling and mediates RVD when transfected
into mouse T lymphocytes (Deutsch & Chen 1993). ISK channel, which is slowly
activating and usually associates with KVLQT1 to form MinK channels (Barhanin et al.
1996), is activated in Xenopus oocytes during hyposmotic exposure (Busch, Varnum,
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Adelman & North 1992). More recently TASK-2 has also been shown to exhibit
hyposmotically activated conductances in Ehrlich Ascites tumor cells (Niemeyer, Cid, &
Sepulveda 2001).

Chloride Channels Involved in RVD
Present research suggests that in most preparations a single chloride (or anion)
channel type is responsible for the majority of chloride efflux during RVD. This channel
has been named VSOR, for volume-sensitive outward-rectifying chloride channel
(Okada, Oiki, Hazama & Morishima 1998), VSOAC, for volume-sensitive organic
osmolytes-anion channels (Jackson & Strange 1994), or VRAC, for volume-regulated
anion channel (Nilius & Droogmans 2001). The current mediated by this channel has
been named ICl,swell (Nilius et al. 1999) and ICl,vol (Hoffman & Mills 1999). VRAC is
activated in response to hyposmotic exposure in almost all preparations. Although VRAC
is commonly expressed functionally, its molecular identity has remained a mystery.
While the molecular nature of VRAC is unknown, the electrophysiological
properties of ICl,swell can distinguish it from other known cloned chloride channels. ICl,swell
has four basic electrophysiological characteristics. First, ICl,swell is outwardly rectified,
that is, conductance increases at more positive membrane potentials. The second
characteristic is inactivation of currents elicited at highly positive membrane potentials.
The degree of inactivation appears to vary by cell type, with the midpoint of inactivation
occurring at +40 mV in T84 epithelial cells (Braun and Schulman, 1996) and +105 mV
for myeloma cells (Levitan and Garber, 1995). The third characteristic is that VRAC has
an Eisenmen’s Sequence I of ion permeabilities (Nilius & Droogmans 2001), which
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indicates that the ion flowing through the channel has a weak energy of binding to the
cationic changes within the channel as compared to the energy needed to unbind the ion
from water molecules (Wright & Diamond 1977). Thus, its permeability sequence is:
SCN- > I- > NO3- > Br- > Cl- > HCO3- > F- > isethionate > gluconate > glycine > taurine
> aspartate, glutamate. Chloride is the main osmolyte flowing through VRAC in
conditions established for most electrophysiological studies, however it has been reported
that cellular release of taurine (Olson & Li 1997) and aspartate (Abdullaev, Rudkauskaya,
Schools, Kimelberg & Mongin 2006) also occurs via this channel. The fourth
characteristic, and that for which VRAC got its name, is activation by cell swelling. The
basal conductance of VRAC is very low, and it is not until swelling has occurred that it is
activated (Jackson & Strange 1995).
A number of cloned chloride channels have been proposed to be the molecular
source of VRAC currents. ClC-2 is a chloride channel of the ClC gene family that has
been shown to activate during cell swelling (Grunder, Thiemann, Pusch & Jentz 1992)
and hyperpolarization (Thiemann, Grunder, Pusch & Jentsch 1992). However, ClC-2 has
an inwardly rectified current-voltage relationship and a selectivity sequence of Cl - > I- >>
Aspartate (Duan, Ye, Britton, Horowitz & Hume 2000). Another member of the ClC
family, ClC-3, has many characteristics that are similar to VRAC, such as outward
rectification and anion selectivity (Strange 1998, Jentsch, Friedrich & Schriever 1999,
Hume, Duan, Collier, Yamazaki & Horowitz 2000). ClC-3 has a large basal conductance,
which is in contrast to the very minimal, if any, basal conductance that is demonstrated
by VRAC. Also, ClC-3 is inhibited by PKC, which has been found to stimulate VRAC
(Okada et al. 1998, Strange 1998).
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Although VRAC seems to be ubiquitously expressed, in certain preparations other
chloride channels have also activated during hyposmotic exposure. BCl, sometimes
called maxi Cl-, channels are activated by hyposmotic conditions in newborn rat cardiac
myocytes (Coulombe & Coraboeuf 1992), mouse neuroblastoma cells (Falke & Misler
1989) and primary cultures of rat cortical astrocytes (Jalonen 1993). SCl, or mini Cl -,
channels have also been observed in Ehlich ascites tumor cells (Christenson & Hoffmann
1992) and bovine ciliary epithelium (Zhang & Jacob 1997). The calcium activated
chloride channels, CaCCs, also contribute to RVD (Jentsch 1996, Hoffmann & Mills
1999, Nilius & Droogmans 2001).

D. Summary of Background Literature
Edema is a common cause of delayed death after traumatic brain injuries and
stroke (Markiewicz 2006) and astrocytes are commonly observed to swell during those
situations (Barron et al. 1988, Kimelberg et al. 2000, Mongin & Kimelberg 2005, Somjen
2004). Astrocyte swelling is thought to cause a decrease in brain ECS and release EAAs
and other harmful substances in these pathological situations (Sykova & Chvatal 2000).
Thus research has focused on the mechanisms of RVD in astrocytes. The mysterious
current ICl,swell is important for RVD and is expressed in astrocytes (Darby et al. 2003,
Abdullaev et al. 2006). The molecular identity of ICl,swell is not known and the method of
its activation is poorly understood. It would seem that exogenous ATP, acting via P2Y
receptors, plays some role in ICl,swell activation. In one study P2Y nucleotide receptors
play a critical role in the activation of ICl,swell (Darby 2003), however another study
indicates P2Y receptors only modify its activity (Mongin & Kimelberg 2003). Neither
24

study was able to conclusively answer whether P2Y signaling is necessary or sufficient
for ICl,swell activation.
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II. Specific Aims

Specific Aim I
The first goal of this study was to identify and characterize the hyposmotically
activated current ICl,swell in human 1321N1 astrocytoma cells. This was to be
accomplished using voltage clamp techniques in both physiological and chloride currentisolating conditions. ICl,swell was also identified pharmacologically using the drug DCPIB.
Specific Aim II
The second goal of this study was to determine if P2Y receptor expression is
necessary for ICl,swell activation in human 1321N1 astrocytoma cells. If P2Y receptors
were found to be associated with ICl,swell activation by hyposmotic exposure (HOE), a
secondary goal of this aim was to determine which receptor subtype, P2Y1 or P2Y2, is
responsible. This was to be accomplished using voltage clamp techniques and by
examining responses to hyposmotic exposure in three subtypes of the 1321N1 cells; one
with P2Y1 receptor expression, one with P2Y2 receptor expression and another lacking
P2Y receptor expression. In addition, the drug PPADS was used as a broad spectrum P2Y
receptor antagonist.
Specific Aim III
The final goal of this study was to determine if P2Y receptor activation was
sufficient to initiate ICl,swell activation in the absence of HOE. This was to be
accomplished using voltage clamp techniques and by exposing the same cell subtypes
mentioned above to exogenous ATP under isosmotic conditions.

26

III. Materials and Methods
A. Materials
The materials, equipment and software used during the studies performed for this
thesis are listed here in alphabetical order. The reader can use this table to find the
manufacturing company’s name, location and, when available, the item number for each
product.
Materials
Name
12 mm Coverslips
Acrylamide
Alexafluor 568
Ammonium Persulfate
-Actin Antibody

Item #
12-545-80
254
A11036
A3678
600-401-886

Company
Fisher Scientific
Amresco
Invitrogen
Sigma-Aldrich
Rockland

BCA* Solutions
CaCl2

B9643, C2284
133205

Sigma-Aldrich
J.T. Baker Chemical Co.

CsCl
CsOH
DCPIB*
Dextrose

C4036
C8518
1540
1910

Sigma-Aldrich
Sigma-Aldrich
Tocris Biosciences
J.T. Baker Chemical Co.

DMEM* low glucose
ECF Western Blotting
Kit
EGTA*
Fetal Bovine Serum
Geneticin (G418)

D5523
RPN5870

Sigma-Aldrich
Amersham Biosciences

E4378
26140-079
15-394N

Sigma-Aldrich
Invitrogen
Cambrex

Glycine
Hydrochloric Acid
HEPES*

G8898
A144Sl-212
H-9136

Sigma-Aldrich
Fisher Scientific
Sigma-Adrich

St. Louis, MO
Carlsbad, CA
East
Rutherford, NJ
St. Louis, MO
Pittsburg, PA
St. Louis, MO

Immuno-Blot PVDF
Membrane
KCl
KH2PO4
KOH
Mammalian Cell Lysis
Kit

162-0174

Biorad

Hercules, CA

P-217
P-5379
5-3140
MCL-1

Fisher Scientific
Sigma-Aldrich
Sigma-Aldrich
Sigma-Aldrich

Pittsburg, PA
St. Louis, MO
St. Louis, MO
St. Louis, MO
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Location
Pittsburg, PA
Solon, OH
Carlsbad, CA
St. Louis, MO
Philadelphia,
PA
St. Louis, MO
Phillipsburg,
NJ
St. Louis, MO
St. Louis, MO
Ellisville, MO
Phillipsburg,
NJ
St. Louis, MO
Piscataway, NJ

MgCl2
Microscope slides

MX0045-1
48312-003

MCB Reagents
VWR

Mounting Media
Na2ATP
Na2HPO4
NaCl
NaOH

M01
A6419
S-0876
S-9625
S318-3

Biomeda
Sigma-Aldrich
Sigma-Aldrich
Sigma-Aldrich
J.T. Baker Chemical Co.

Normal Goat Serum
P2Y1 and P2Y2
Antibodies
Paraformaldehyde
Penicillin/Streptomycin
PPADS*
Precision Plus Protein
Ladder
Protein Standards
SDS*
StrepActin AP
Sucrose
TEA*
TEMED*
Thin Wall Capillary
Tubes
Trizma Base
Trypsin 0.25%
Tryton X100
Tween-20

64292
APR-009, APR-010

Invitrogen
Alomone Labs

P6148
15070-063
P-178
161-0374

Sigma-Aldrich
Invitrogen
Sigma-Aldrich
Biorad

P0914-5AMP
S3771
161-0382
S5-3
T-2265
761
TW120F-4

Sigma-Aldrich
Sigma-Aldrich
Biorad
Fisher Scientific
Sigma-Aldrich
Amresco
World Precision
Instruments inc.
Sigma-Aldrich
Invitrogen
Sigma-Aldrich
Sigma-Aldrich

T1503
15050
X-100
P5927-100mL

West Chester,
PA
Foster City, CA
St. Louis, MO
St. Louis, MO
St. Louis, MO
Phillipsburg,
NJ
Carlsbad, CA
Jerusalem,
Israel
St. Louis, MO
Carlsbad, CA
St. Louis, MO
Hercules, CA
St. Louis, MO
St. Louis, MO
Hercules, CA
Pittsburg, PA
St. Louis, MO
Solon, OH
Sarasota, FL
St. Louis, MO
Carlsbad, CA
St. Louis, MO
St. Louis, MO

* abbreviations are defined in the abbreviation section below.

Equipment and Software
Axopatch 200A amplifier
Clampex 8.2
Clampfit 8.2
Microsoft Office 2003
Narishige PP-83 puller
Nikon Phase-contrast
Microscope
Perfusion System
Power Supply
Scanning (ECF) Machine
Spectrometer
Vapor Pressure
Osmometer

200A

PP-83
TMS-F 211164
CF-8VS Valve
Assembly
PowerPac Basic
FLA-5100
U-2000
5500

Axon Instruments
Axon Instruments
Axon Instruments
Microsoft
Narishige
Nikon

Union City, CA
Union City, CA
Union City, CA
Redmond, WA
East Meadow, NY
Tokyo, Japan

Cell Micro-Controls

Norfolk, VA

Biorad
Fujifilm
Hitachi
Wescor

Hercules, CA
Valhala, NY
Brisbane, CA
Logan, UT
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B. Abbreviations
BCA = bicinchoninic acid, DCPIB = 4-[(2-Butyl-6,7-dichloro-2-cyclopentyl-2,3dihydro-1-ox o-1H-inden-5-yl)oxy]butanoic acid, DMEM = Dulbecco’s modified Eagles
medium, EGTA = ethylene glycol tetraacetic acid, FBS = fetal bovine serum, HEPES =
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, PPADS = pyridoxalphosphate-6azophenyl-2',4'-disulphonic

acid,

SDS

=

sodium

dodecyl

sulfate,

TEA

=

tetraethylammonium, TEMED = tetramethylethylenediamine.

C. Cell Culture
Human 1321N1 astrocytoma cells are used throughout these experiments. As
originally cloned, this cell line does not express any of the P2Y subtypes (Erb 1995).
Three genetic variants of the human 1321N1 astrocytoma cell line were obtained from
Dr. Natalia Chorna of the University of Puerto Rico, San Juan, Puerto Rico. One cell line
was stably transfected with the P2Y1 receptor subtype (P2Y1 cells), another with the
P2Y2 receptor subtype (P2Y2 cells), while the third (Parental cells) retained its P2Y
receptor-lacking genotype (Chorna 2004). Cells transfected with P2Y1 and P2Y2
receptors also had been simultaneously transfected with resistance to geneticin, an
antibiotic similar in structure to gentamicin B1 that blocks protein synthesis in both
prokaryotic and eukaryotic cells. Cells were shipped in large flasks containing
Dulbecco’s modified Eagle’s medium. Upon arrival cells were replated in small flasks
and grown to ~90% confluency. Then they were removed from the culture surface and
resuspended in media containing DMEM, FBS, glycerol and DMSO before being
aliquoted into 1 mL cryogenic tubes and frozen for long-term storage in liquid nitrogen.
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The cells were cultured in growth medium composed of low glucose DMEM
containing 5% FBS, 100 U/mL penicillin and 100 µg/mL streptomycin. Cells were
maintained at 37ºC in a humidified atmosphere of 5% CO2 and 95% air. To select for the
positively transfected cells, P2Y1 and P2Y2 cells were cultured in growth media that also
contained 0.5 g/L G418. Parental cells were cultured without this drug added. Every 3-4
days the growth media was replaced. Once ~90% confluency was reached, the cells were
treated with 0.25% trypsin for 5 to 15 min to loosen the cells from the culture surface and
the resulting cell suspension was centrifuged. The trypsin solution was removed by
aspiration and the pellet of cells was resuspended in fresh growth media. A fraction of the
cells then was replated. Cells for immunostaining and patch clamp experiments were
grown on cleaned and sterilized 12 mm coverslips under the same conditions.

D. Electrophysiological Recordings
Recording Using PBS as the Extracellular Solution
Astrocytoma cells were plated onto 12 mm diameter glass coverslips at least one
day prior to recording. Coverslips were placed on a Nikon TMC inverted phase-contrast
microscope and perfused at a rate of 1-2 mL/sec (35ºC) with a phosphate buffered
solution (PBS) containing (in mM): NaCl (147), KH2PO4 (0.5), Na2HPO4 (3.2), CaCl2
(1), MgCl2 (0.5), dextrose (5), KCl (2.7). The pH was adjusted to 7.3 using NaOH. The
final osmolarity of the solution was determined to be 300 mOsm using a vapor pressure
osmometer. Hyposmotic solutions were made by initially adding only 73.5 mM NaCl,
and then adding NaCl until the final osmolarity was 200 mOsm. Patch pipettes pulled
from thin-walled glass capillary tubes by a Narishige PP-83 puller and had a resistance of
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3-9 MΩ when filled with a solution containing (in mM): KCl (135), CaCl2 (0.2), MgCl2
(1), EGTA (10), Na2ATP (3), HEPES (10), and dextrose (5.5). The free calcium
concentration was calculated to be 8.9 nM using Maxchelator program WEBMAXCLITE
v1.15 (http://maxchelator.stanford.edu) and the pH was adjusted to 7.3 using KOH. The
final osmolarity of the solution was determined to be 300 mOsm using a vapor pressure
osmometer. The electrode was manipulated so that the tip lightly touched a cell’s
membrane. Light suction was applied via a syringe, and when the series resistance was
greater than 1 gigaohm, more negative pressure was applied to break the cell membrane
inside the electrode. A stable whole-cell recording was defined when the cell had a seal
resistance between 100 and 500 MΩ and a capacitance between 15 and 80 pF lasting for
at least five minutes before the experiment was conducted. Stable cells were held in
voltage clamp mode at a holding potential (VH) of –70 mV using an Axopatch 200A
amplifier. Every 30 sec, a series of voltage pulses was applied that increased from –100
mV to +80 mV in 20 mV increments. Pulses were held for 100 msec. For some
experiments, tetraethylammonium (TEA) or pyridoxalphosphate-6-azophenyl-2',4'disulphonic acid (PPADS) was added to the PBS once a stable recording was obtained.

Recording Using CsCl in the Extracellular Solution
Experiments using CsCl solutions were performed in the same manner as those
done in PBS solution. Both isosmotic and hyposmotic CsCl solutions contained (in mM):
CsCl (100), HEPES (10), CaCl2 (1), MgCl2 (0.5), and dextrose (5). The pH was adjusted
to 7.3 using CsOH. For isosmotic CsCl solution, approximately 100 mM sucrose was
added until the solution had an osmolarity of 300 mOsm. Hyposmotic solutions were
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made by adding sucrose until the osmolarity was 200 mOsm. Patch pipettes pulled from
thin-walled glass capillary tubes by a Narishige PP-83 puller and had a resistance of 3-9
MΩ when filled with a solution containing (in mM): CsCl (100), CaCl2 (1), MgCl2 (1),
EGTA (10), Na2ATP (5), HEPES (10), glucose (5.5), and sucrose (100). The free calcium
concentration was calculated to be 8.9 nM using Maxchelator program WEBMAXCLITE
v1.15 (http://maxchelator.stanford.edu) and the pH was adjusted to 7.3 using CsOH. The
final osmolarity of the solution was determined to be 300 mOsm using a vapor pressure
osmometer. Cell recordings were established with the cells perfused in PBS. Stable cells
exhibited seal resistances between 100 and 500 MΩ, capacitances between 15 and 80 pF
and steady resting currents for at least 5 minutes. Once the recording was determined to
be stable, the extracellular solution was switched to isosmotic CsCl solution and the
holding voltage was changed to VH = 0 mV. Every 30 seconds a series of voltage pulses
was applied that increased from –100 mV to +80 mV in 20 mV increments. Pulses were
held for 100 msec. For some experiments, DCPIB was used during recordings as a
VRAC inhibitor or ATP was added to the perfusion solution.

E. Immunostaining
Solutions
Phosphate buffer was made by adding 135 mM NaCl and 2.5 mM Na2HPO4 to
deionized distilled water (ddH2O) and then adjusting the to a pH to of 7.4 with 1 N HCl.
Paraformaldehyde fixative solution was made by adding 0.5, 1, 2, or 4% (w/v)
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paraformaldehyde to the phosphate buffer. 1% Triton X-100 was made by adding 1% v/v
Triton X-100 to phosphate buffer.

Procedure
Cells were grown as described above to 60-90% confluence, washed twice with
phosphate buffer, fixed with 0.5% paraformaldehyde solution for 10 minutes and then
permeabilized by exposure to 1% Triton X-100 for 5 minutes. Fixed cells were first
incubated in 20% normal goat serum in phosphate buffer for 30 min before being
incubated with primary antibody, either rabbit anti-P2Y1 or rabbit anti-P2Y2 diluted to
1:500 in phosphate buffer, for 1 hr at room temperature. The cells were then washed
twice and incubated for 5 min with phosphate buffer. The secondary antibody, Alexafluor
568, was diluted to 1:200 in phosphate buffer and cells were incubated with this solution
for 1 hr at room temperature. The cells again were washed twice and incubated for 5
minutes with the phosphate buffer and then washed twice and incubated with ddH2O.
Coverslips were mounted on microscope slides using aqueous mounting media.
For some studies, specific binding was blocked by incubating antibodies with
control antigen provided by the primary antibody’s manufacturer prior to exposing the
cells. Using methods provided by the manufacturer (Alomone Labs) control antigen was
mixed with primary antibody at equal concentrations (w/w) and then incubated for 1 hr at
room temperature. The solution then was centrifuged at 10,000 x g for 5 min and the
resulting supernatant used in place of the primary antibody.
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F. Western Blots
Solutions
Blocking powder, ECF substrate, secondary antibodies and tertiary antibodies were
acquired as part of the ECF Western Blotting Kit. Mammalian cell lysis buffer contained
150 mM NaCl, 50 mM Tris-HCL, 1 mM EDTA, 0.1% SDS, 0.5% DOC, 1% Igepal and a
cocktail of protease inhibitors supplied in the lysis kit that contained 4-(2-aminoethyl)
benzenesulfonyl fluoride (AEBSF), pepstatin A, bestatin, leupeptin, aprotinin and transepoxysuccinyl-L-leucyl-amido(4-guanidino)-butane (E-64) Phosphate buffer solution
(PBS) had a different solute composition than in the electrophysiological studies with (in
mM) NaCl (147), KH2PO4 (1.5), Na2HPO4 (8), CaCl2 (1), MgCl2 (0.5), dextrose (5) and
KCl (2.7). Loading buffer was a 50 mM Tris-HCl solution that contained 25% (v/v)
glycerol, 2% (w/v) SDS, 1% (w/v) bromophenol blue and 5% (v/v) -mecaptoethanol.
Running buffer was an aqueous solution of 0.1% (w/v) SDS, 0.3% (w/v) trizma base and
1.44% (w/v) glycine. Transfer buffer was an aqueous solution of 0.05% (w/v) SDS, 0.3%
(w/v) trizma base and 1.44% (w/v) glycine. Wash buffer was composed of PBS with 3%
(v/v) Tween added. Blocking solution was made by adding 5% (w/v) blocking powder to
wash buffer.

Cell Lysing
Cells grown in 100 mm culture dishes as described above were lysed using
Mammalian Cell Lysis Kit. Adherent cells were washed twice with PBS and then
incubated on ice with 100 µL of Mammalian Cell Lysis buffer for 15 minutes. Cell
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debris was extracted by centrifugation at 12,000 x g for 15 minutes. The remaining cell
lysate solution was pipetted into a 1.5 mL Eppendorf tube and stored at -70º C.
To determine protein concentration in this solution, the BCA method was used
with a colorometric kit from Sigma-Aldrich Inc. and the samples and standards measured
with a spectrophotometer. Briefly, 1 mL of BCA solution was added to each sample and
standard, and heated at 40ºC for 25 minutes. The optical density of each standard at 562
nm then was measured in a spectrophotometer and a regression line was created, with
typical R2 values of > 0.96. Protein standards were made by adding 0, 5, 10, 30 and 50
µL of 1 mg BSA/ml protein to appropriate amounts of ddH2O to bring the volume to 100
µL. Protein samples were made by adding 10 µL of cell lysate to 90 µL of ddH2O. The
samples were measured under identical conditions and protein concentrations were
calculated using the regression line.

Gel Electrophoresis
Western blotting was performed to analyze the presence or absence of P2Y
subtypes in each of the three cell lines. 10% SDS-polyacrylamide gels were made from
the following reagents (in mL): acrylamide (3.3), ddH2O (4.1), 1.5 M Tris buffer (2.5),
10% SDS (0.1), TEMED (0.005) and ammonium persulfate (0.05). The stacking gel was
made with the same ingredients except 0.5 M Tris buffer and 0.01 mL of TEMED were
used.
Loading buffer was added to an equal volume of cell lysate and boiled for 5 min
prior to loading into the gel. A protein ladder was placed in separate lanes of the gel. The
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Power Pac Basic power supply was set at 50 mA until the samples had run through the
stacking gel and then increased to 100 mA for one to two hours.

Western Transfer and Imaging
Protein contents of the gel were transferred to a polyvinylidene difluoride (PVDF)
membrane using electrophoresis. The transfer was run overnight at 90 mA. After transfer,
the membrane was washed with wash buffer and incubated in 5% blocking solution for 1
hr. Primary antibodies were diluted into 5% blocking buffer and incubated for one hr.
Anti-β-Actin was used at a dilution of 1:1000 and both Anti-P2Y1 and Anti-P2Y2 were
used at a dilution of 1:200. After incubation with the primary antibody the membrane
was washed twice for 10 min with wash buffer. FITC-conjugated secondary antibody was
diluted to 1:600 with wash buffer and incubated with the membrane for one hr.
StrepTactin AP-conjugate was added at a 1:5000 concentration at the same time as the
secondary antibody to label the protein ladder. The alkaline-phosphatase-conjugated
tertiary antibody to fluorescein was diluted to 1:1000 in wash buffer and incubated with
the membrane for 30 min. The membrane then was washed using wash buffer a final
time. ECF substrate was added to the membrane, which then was immediately placed into
the ECF scanning machine. Fluorescence was excited at 488 nm and the emission was
recorded with a digital imaging system. The resulting image was viewed and edited on
Micrososoft Picture Manager.
At times, control antigens were preincubated with the P2Y antibodies to test for
cross reactivity of the primary antibodies. Protocol for incubation with control antigen is
described in section III.E. Immunostaining.
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G. Data Analysis and Calculations
Electrophysiological raw data were recorded using Clampex 8.2 (Axon
Instruments) and then transferred to Excel (Microsoft) for graphical analysis.
Calculations made from these data include the reversal potential, cell conductance and
current inhibition. Both reversal potential and conductance were determined by
calculating the equation for a line connecting data points on either side of the voltage axis
(e.g. Figure 2). The slope of this line was used as an estimate of cell slope conductance
and the intercept of this line on the voltage axis was used as an estimate of the membrane
reversal potential.

Calculating TEA Current Inhibition
The magnitude of current inhibition by TEA was calculated using Microsoft
Excel using current-voltage plots of the data before the addition of TEA (blue) and after
the application of 10 mM TEA to the bath solution (red) as shown in Figure 3. Since TEA
inhibited only the outward rectifying component of the cell conductance, currents were
measured at +80 mV. The total current prior to TEA treatment (IT) and the current
remaining after TEA treatment (ID) were compared to the extrapolated-baseline current at
+80 mV (IEB). IEB was estimated by calculating a linear regression line using the currents
measured at -100 mV, -80 mV and -60 mV. The calculation of percent TEA-current
inhibition is performed as follows:

Percent TEA-current inhibition = [(IT – ID)/(IT – IEB)] x 100%
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Current (pA)
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II

0

Voltage (mV) 100

-3000
Figure 2 Example of cell reversal potential and conductance analysis. The blue data
set contains currents measured from a cell in isosmotic CsCl (II). The pink data set
contains currents from the same cell 5 min after the bath solution was changed to
hyposmotic CsCl solution (IH). The yellow data set contains the currents resulting from
hyposmotic CsCl solution plus 20 M DCPIB (ID). Lines segments between currents on
either side of the abscissa were constructed for each data set. These lines were used to
estimate conductance and reversal potential.
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Calculating Drug-induced Current Inhibition
Both PPADS and DCPIB were used to inhibit hyposmotically activated current.
The magnitude of current inhibition by these drugs was calculated using Microsoft Excel
to create a current-voltage plot of the data as shown in Figure 2. Currents elicited during
isosmotic CsCl conditions (II), hyposmotic CsCl conditions (IH) and hyposmotic CsCl
conditions plus 20 µM DCPIB (ID) are represented by the blue, pink and yellow data sets,
respectively. The calculation of percent drug-induced current inhibition is as follows:

Percent hyposmotic current inhibition = [(IH – ID)/(IH – II)] x 100%

H. Statistics
Data were analyzed by ANOVA, or Students t-test for paired or unpaired samples,
as appropriate and significance indicated for p<0.05. All values a reported as the mean ±
SEM. Clampfit 8.2 (Axon Instruments) was used for electrical recording analysis and
statistical analysis.
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Current (pA)

IT

ID
IEB

Voltage (mV)

-150

150

-200
IEB = 1.25 x V + 83.333
Figure 3 Example of cell membrane current analysis. The blue data set contains
currents measured from a cell in isosmotic PBS without TEA. The red data set contains
currents from the same cell 5 min after application of isosmotic PBS with 10 mM TEA.
Data points for membrane voltages of -100 mV to -60 mV without TEA were used to
create the line that represents non-rectified current for cells in isosmotic conditions. The
equation for this line is displayed in the bottom right hand corner. Also on the right are
indicators of the extrapolated-baseline current at +80 mV, IEB, TEA-inhibited current, ID,
and total current, IT, used in calculations as described in the text.
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IV Results
A. 1321N1 Human Astrocytoma Cells Exhibit TEA Sensitivity
Whole cell voltage clamp recordings in isosmotic PBS revealed a number of basal
electrophysiological attributes of 1321N1 astrocytoma cells. Under these conditions
P2Y1 and P2Y2 cells had similar basal whole-cell slope conductances, measured at 0 pA
and normalized to the cell capacitance of 0.1135 ± 0.0301 nS/pF and 0.1060 ± 0.0186
nS/pF, respectively. Parental cells averaged a larger basal conductance of 0.2887 ±
0.1419 nS/pF, although it was not significantly different from the receptor expressing
cells (p = 0.33) (Figure 4A). Reversal potentials were quite negative for each cell type.
P2Y1, P2Y2 and Parental cells averaged reversal potentials of -68.4 ± 3.3 mV, -68.1 ±
7.0 mV and -60.5 ± 5.6 mV (Figure 4B). All cells studied had capacitances between 10
and 60 pF.
All three cell lines exhibited TEA-sensitive outwardly rectified currents while
perfused with isosmotic PBS, although in parental cells this was not statistically
significant. 10 mM TEA inhibited currents measured at +80 mV by 88.3 ± 9.2% 77.9 ±
10.1%, and 28.4 ± 24.4% in P2Y1, P2Y2 and Parental cells, respectively (Figure 5A).
Figure 5B shows the TEA dose-response curve in P2Y1 cells. The curve was fit using the
Michaelis-Menten equation with a calculated IC50 of 0.37 mM and maximal inhibition of
88%.
During perfusion with 10 mM TEA whole cell normalized conductance and
reversal potential were measured in each cell type. After the addition of TEA there was
no significant change in slope conductance in P2Y1 (p = 0.13), P2Y2 (p = 0.46) or
Parental cells (p = 0.32) (Figure 4A). Similarly, the reversal potential was not found to
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A

B

Figure 4 The effect of TEA on whole cell conductance and reversal potential in
1321N1 astrocytoma cells. A) Whole cell normalized slope conductance for P2Y1
(n=8), P2Y2 (n=7) and Parental (n=4) cells during perfusion with isosmotic PBS and
isosmotic PBS plus 10 mM TEA. B) Reversal potentials for P2Y1 (n=8), P2Y2 (n=7) and
Parental (n=4) cells during perfusion with isosmotic PBS and isosmotic PBS plus 10 mM
TEA.
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Figure 5 Effect of TEA on outwardly-rectified potassium currents in 1321N1
astrocytoma cells. A) Percent of current inhibited at +80 mV by TEA in isosmotic PBS.
Measurements were taken at +80 mV in P2Y1 receptor transfected cells (n=8), P2Y2
receptor transfected cells (n=7) and Parental cells (n=4). (* indicates p < 0.05) B) TEA
concentrations of 0.5 mM (n=3), 1 mM (n=3), 5 mM (n=4) and 10 mM (n=8) were used
to inhibit outwardly rectified potassium currents in P2Y1 receptor transfected cells in
isosmotic PBS. The curve was fit using first order kinetics equation calculated assuming
the curve passes through the origin (r2 = 0.81). The IC50 was determined to be 0.37 mM.
Fitted curve was calculated using Clampfit 8.2.
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change after application of TEA in P2Y1 (p = 0.69), P2Y2 (p = 0.46) or Parental cells (p
= 0.79).

B. Current activated in hyposmotic PBS is PPADS-sensitive in cells
expressing P2Y receptors.
The electrophysiological response to hyposmotic exposure (HOE) and subsequent
addition of 100 µM PPADS, a specific nucleotide receptor blocker, was examined in each
cell type by voltage clamp technique in PBS. Isosmotic and hyposmotic PBS had
osmolarities of 300 mOsm and 200 mOsm, respectively, and in all conditions, 10 mM
TEA was present as discussed in Materials and Methods. Raw electrophysiological data
for typical P2Y1, P2Y2 and Parental cells are shown in Figures 6, 7, and 8, respectively.
P2Y1 and P2Y2 cells exhibited similar electrophysiological responses to HOE. Both cell
types demonstrated an increase in current amplitude within 5 to 10 min of HOE that was
inhibited by 100 µM PPADS (Figures 6A and 7A). The hyposmotically activated currents
in P2Y1 and P2Y2 cells were outwardly rectified (Figures 6E and 7E) and also showed
time inactivation at depolarizing potentials (Figures 6C and 7C). While Parental cells also
increased in current after HOE, they demonstrated no outward rectification, time
inactivation or sensitivity to PPADS (Figure 8).
Cumulative data from these experiments allowed for analyses of the
hyposmotically activated conductance and change in reversal potential. All cell types
increased their whole-cell normalized slope conductance during HOE, measured at 0 pA,
with Parental cells nearly doubling and receptor expressing cells more than doubling
(Figure 9A). In contrast the reversal potentials of P2Y1 and P2Y2 cells significantly
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Figure 6 P2Y1 receptor transfected cells have a hyposmotically activated current
that is inhibited by 100 µM PPADS in PBS. A) Illustrated is a strip chart derived from
data obtained from a P2Y1 cell initially bathed in isosmotic PBS. TEA (10 mM) was
added to the perfusate as indicated and the cell was subsequently exposed to hyposmotic
PBS and then hyposmotic PBS plus 100 µM PPADS. Cell currents recorded while the
cell was perfused with B) isosmotic PBS, C) hyposmotic PBS and D) hyposmotic PBS
plus 100 µM PPADS. Location of current traces in the strip chart is similarly indicated.
E) Current-voltage relationships for the three current traces in B) through D). (* indicates
noise artifact.)
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Figure 7 P2Y2 receptor transfected cells have a hyposmotically activated current
that is inhibited by 100 µM PPADS in PBS. A) Illustrated is a strip chart derived from
data obtained from a P2Y2 cell initially bathed in isosmotic PBS. TEA (10 mM) was
added to the perfusate as indicated and the cell was subsequently exposed to hyposmotic
PBS and then hyposmotic PBS plus 100 µM PPADS. Cell currents recorded while the
cell was perfused with B) isosmotic PBS, C) hyposmotic PBS and D) hyposmotic PBS
plus 100 µM PPADS. Location of current traces in the strip chart is similarly indicated.
E) Current-voltage relationships for the three current traces in B) through D).
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Figure 8 Parental cells have a hyposmotically activated current that is not inhibited
by 100 µM PPADS in PBS. A) Illustrated is a strip chart derived from data obtained
from a Parental cell initially bathed in isosmotic PBS. TEA (10 mM) was added to the
perfusate as indicated and the cell was subsequently exposed to hyposmotic PBS and then
hyposmotic PBS plus 100 µM PPADS. Cell currents recorded while the cell was perfused
with B) isosmotic PBS, C) hyposmotic PBS and D) hyposmotic PBS plus 100 µM
PPADS. Location of current traces in the strip chart is similarly indicated. E) Currentvoltage relationships for the three current traces in B) through D).
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Figure 9 Effects of TEA, hyposmotic exposure and PPADS on whole cell
conductance and reversal potential in 1321N1 astrocytoma cells. A) Whole cell
normalized conductance for P2Y1 (n=4), P2Y2 (n=4) and Parental (n=4) cells during
perfusion with isosmotic PBS plus 10 mM TEA, hyposmotic PBS plus 10 mM TEA and
hyposmotic PBS plus 10 mM TEA and 100 µM PPADS. B) Reversal potentials for P2Y1
(n=4), P2Y2 (n=4) and Parental (n=4) cells during perfusion with isosmotic PBS plus 10
mM TEA, hyposmotic PBS plus 10 mM TEA and hyposmotic PBS plus 10 mM TEA
with 100 µM PPADS added. (* indicates p < 0.05)
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depolarized (p = 0.0064 and 0.0458, respectively) during HOE, while the reversal
potential of Parental cells did not depolarize (Figure 9B).
The addition of 100 µM PPADS to hyposmotic medium had no significant effect
on whole cell conductance or reversal potential, but did inhibit current at higher voltages
in P2Y1 and P2Y2 cells (Figure 9). Whole-cell normalized slope conductance of both
P2Y1 and P2Y2 cells showed no significant change (p = 0.4708 and 0.3202, respectively)
after the addition of PPADS to the hyposmotic PBS. Similarly, P2Y1 and P2Y2 cells
demonstrated no significant change (p = 0.3542 and 0.1446, respectively) in reversal
potential in response to the drug application. However, when the current elicited by HOE
was measured at +80 mV there was a significant inhibition of current in P2Y1 and P2Y2
cells of 57.3 ± 8.3% and 51.2 ± 10.1%, respectively. The extent of inhibition at higher
voltages in these cell types also can be seen in the current-voltage plots in Figures 6C and
7C. The Parental cells showed no change whole-cell conductance, reversal potential or
current at depolarized potential in response to PPADS (Figures 9 and 10).
In separate experiments P2Y1 and P2Y2 cells were perfused with 100 µM
PPADS prior to HOE (Figures 11-13). Strip chart recordings (Figures 11A and 12A)
demonstrated little increase in current amplitude during HOE. The inactivation seen in
previous experiments (Figures 6 and 7) was also absent in the presence of PPADS
(Figures 11C and 12C). Whole cell conductance did increase during HOE in the presence
of PPADS (Figure 13A),but not significantly, and definitely not to the same extent as
without PPADS. Also, in the presence of PPADS there is no significant change in
reversal potential due to HOE in either receptor cell type (Figure 13B). In P2Y1 and
P2Y2 cells, PPADS totally blocked (p =
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Figure 10 PPADS inhibits hyposmotic current in P2Y1 and P2Y2 receptor
transfected cells but not in Parental cells in PBS. Percent inhibition of hyposmotically
activated current, measured at +80 mV, by 100 µM PPADS in P2Y1 (n=4), P2Y2 (n=4)
and Parental (n=4) cells. Cells were perfused in PBS solution as described in the
Materials and Methods section and subjected to hyposmotic exposure for 5-10 min prior
to addition of PPADS. (* indicates values significantly different from zero p < 0.05)
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Figure 11 P2Y1 receptor transfected cells lack hyposmotically activated current
when treated with 100 µM PPADS prior to hyposmotic exposure. A) Illustrated is a
strip chart derived from data obtained from a P2Y1 cell initially bathed in isosmotic PBS.
TEA (10 mM) was added to the perfusate as indicated and the cell was subsequently
exposed to isosmotic PBS plus 100 µM PPADS and then hyposmotic PBS plus 100 µM
PPADS. Cell currents recorded while the cell was perfused with B) isosmotic PBS, C)
isosmotic PBS plus 100 µM PPADS and D) hyposmotic PBS plus 100 µM PPADS.
Location of current traces in the strip chart is similarly indicated. E) Current-voltage
relationships for the three current traces in B) through D).
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Figure 12 P2Y2 receptor transfected cells lack hyposmotically activated current
when treated with 100 µM PPADS prior to hyposmotic exposure. A) Illustrated is a
strip chart derived from data obtained from a P2Y2 cell initially bathed in isosmotic PBS.
TEA (10 mM) was added to the perfusate as indicated and the cell was subsequently
exposed to isosmotic PBS plus 100 µM PPADS and then hyposmotic PBS plus 100 µM
PPADS. Cell currents recorded while the cell was perfused with B) isosmotic PBS, C)
isosmotic PBS plus 100 µM PPADS and D) hyposmotic PBS plus 100 µM PPADS.
Location of current traces in the strip chart is similarly indicated. E) Current-voltage
relationships for the three current traces in B) through D).
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Figure 13 Reversal potentials for P2Y1 and P2Y2 receptor transfected cells do not
depolarize when treated with 100 µM PPADS prior to hyposmotic exposure. A)
Calculated whole cell conductance for P2Y1 (n=3) and P2Y2 (n=3) cells during
perfusion with isosmotic PBS plus 10 mM TEA, isosmotic PBS plus 10 mM TEA and
100 µM PPADS and hyposmotic PBS plus 10 mM TEA and 100 µM PPADS. B)
Calculated reversal potentials for P2Y1 (n=3) and P2Y2 (n=3) cells during perfusion with
isosmotic PBS, isosmotic PBS plus 10 mM TEA, isosmotic PBS plus 10 mM TEA and
100 µM PPADS and hyposmotic PBS plus 10 mM TEA and 100 µM PPADS. C) Change
in reversal potential for all three cell lines in response to hyposmotic exposure. White
bars are responses to hyposmotic exposure without PPADS in bath solution. Black bars
indicate that PPADS was applied prior to hyposmotic exposure. (* indicates p < 0.05)
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0.0091 and 0.0071, respectively) the depolarization seen when these cells experience
HOE without added drug (Figure 13C).

C. Current activated in hyposmotic CsCl solution is DCPIB-sensitive
The protocol for recording from cells in the CsCl solution was very similar to that
of the PBS experiments, with the exceptions that 100 mM sucrose was a major osmolyte
and the holding potential was 0 mV. In order to better isolate anion currents 1321N1
astrocytoma cells were recorded using bath and pipette solutions with 100 mM CsCl ,
replacing the NaCl and KCl used in PBS (for more information on CsCl solution contents
see Materials and Methods). Since all major ions were distributed equally the across the
cell membrane the reversal potential during whole cell recording was close to 0 mV.
Thus the holding was also set to 0 mV in order to limit the amount of injected holding
current.
Raw electrophysiological data for P2Y1, P2Y2 and Parental cells are shown in
Figures 14, 15, and 16, respectively. P2Y1 and P2Y2 cells exhibit similar
electrophysiological responses to HOE with an increase in current amplitude (Figures 14
and 15). Red lines in Figures 14E and 15E represent the difference between currents
generated under isosmotic and hyposmotic conditions. These current voltage plots
reverse just below and just above 0 mV for P2Y1 and P2Y2 cells, respectively. P2Y2
cells also expressed some degree of outward rectification (Figure 15E). Parental cells did
not consistently demonstrate an increase in amplitude due to HOE (Figure 16).
The hyposmotically activated conductance in P2Y1 and P2Y2 cells was inhibited
by bath application of 20 µM DCPIB, the specific blocker of ICl,swell (Figure 17A).
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Figure 14 P2Y1 receptor transfected cells exhibit a hyposmotically activated
chloride current that is inhibited by 20 µM DCPIB. A) Illustrated is a strip chart
derived from data obtained from a P2Y1 cell initially bathed in isosmotic CsCl solution
(300 mOsm). The cell was subsequently exposed to hyposmotic CsCl solution (200
mOsm) and then hyposmotic CsCl solution plus 20 µM DCPIB. B) Cell currents
recorded while the cell was perfused with B) isosmotic CsCl, C) hyposmotic CsCl
solution and D) hyposmotic CsCl solution plus 20 µM DCPIB. Location of current traces
in the strip chart is similarly indicated. E) Current-voltage relationships for the three
current traces in B) through D) are displayed in black. The red plot represents the
difference in current elicited under hyposmotic and hyposmotic + DCPIB conditions.
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Figure 15 P2Y2 receptor transfected cells exhibit a hyposmotically activated
chloride current that is inhibited by 20 µM DCPIB. A) Illustrated is a strip chart
derived from data obtained from a P2Y2 cell initially bathed in isosmotic CsCl solution
(300 mOsm). The cell was subsequently exposed to hyposmotic CsCl solution (200
mOsm) and then hyposmotic CsCl solution plus 20 µM DCPIB. B) Cell currents
recorded while the cell was perfused with B) isosmotic CsCl, C) hyposmotic CsCl
solution and D) hyposmotic CsCl solution plus 20 µM DCPIB. Location of current traces
in the strip chart is similarly indicated. E) Current-voltage relationships for the three
current traces in B) through D) are displayed in black. The red plot represents the
difference in current elicited under hyposmotic and hyposmotic + DCPIB conditions.
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Figure 16 Flat Parental cells do not exhibit a hyposmotically activated chloride
current that is inhibited by 20 µM DCPIB. A) Illustrated is a strip chart derived from
data obtained from a flat Parental cell initially bathed in isosmotic CsCl solution (300
mOsm). The cell was subsequently exposed to hyposmotic CsCl solution (200 mOsm)
and then hyposmotic CsCl solution plus 20 µM DCPIB. B) Cell currents recorded while
the cell was perfused with B) isosmotic CsCl, C) hyposmotic CsCl solution and D)
hyposmotic CsCl solution plus 20 µM DCPIB. Location of current traces in the strip
chart is similarly indicated. E) Current-voltage relationships for the three current traces in
B) through D).
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Figure 17 DCPIB inhibits hyposmoticly-activated chloride current in P2Y1 and
P2Y2 receptor transfected cells but not in flat Parental cells. A) Calculated whole cell
conductance for P2Y1 (n=4), P2Y2 (n=4) and Parental (n=2) cells during perfusion with
isosmotic CsCl, hyposmotic CsCl and hyposmotic CsCl plus 20 µM DCPIB. B) Percent
inhibition of hyposmotically activated current, measured at +80 mV, by 20 µM DCPIB in
P2Y1 (n=4), P2Y2 (n=4) and Parental (n=2) cells. Cells chosen for these experiments
were identified as morphologically “flat” visually by phase-contrast microscopy. Cells
were then perfused in CsCl solution as described in the Materials and Methods section
and subjected to hyposmotic exposure for 5-10 mins prior to addition of DCPIB. (*
indicates p < 0.05)
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Average whole cell normalized conductance for P2Y1 and P2Y2 cells increased from
0.0850 ± 0.0162 nS/pF and 0.0747 ± 0.0201 nS/pF to 0.1628 ± 0.0442 nS/pF and 0.1235
± 0.0247 nS/pF, respectively. Subsequent application of DCPIB caused a decrease in
conductance to 0.1233 ± 0.0298 nS/pF and 0.0760 ± 0.0232 nS/pF for P2Y1 and P2Y2
cells, respectively. The hyposmotically activated current, measured at +80 mV, was
reduced by 32.6 ± 7.6% and 75.2 ± 10.1% for P2Y1 and P2Y2 cells, respectively (Figure
17B). Parental cells did not experience any decrease in conductance or current as a result
of DCPIB application (Figure 17).
Initial experiments targeted cells that were morphologically flat (Figures 14-17).
This choice made acquiring a stable voltage clamp recording difficult to obtain and in the
case of Parental nearly impossible (note the n = 2 for flat Parental cells in Figure 17).
Thus, an additional subset of morphologically rounder cells was chosen for analysis.
Different results were obtained when recording from round compared with flat Parental .
Raw electrophysiological data for round P2Y1 and Parental cells are shown in
Figures 18 and 19, respectively. Rounded P2Y1 and Parental cells exhibited similar
electrophysiological responses to HOE with an increase in current amplitude. Red lines in
Figures 18E and 19E represent the difference between currents generated under
hyposmotic and hyposmotic plus DCPIB conditions for P2Y1 and Parental cells,
respectively. These currents demonstrated outward rectification and reversal potentials
just above 0 mV for both P2Y1 and Parental cells.
The hyposmotically activated conductance in round P2Y1 and Parental cells was
inhibited by bath application of 20 µM DCPIB (Figure 20A). Average whole cell
normalized conductance for round P2Y1 and Parental cells increased from 0.1330 ±
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Figure 18 Rounded P2Y1 receptor transfected cells exhibit a hyposmotically
activated chloride current that is inhibited by 20 µM DCPIB. A) Illustrated is a strip
chart derived from data obtained from a P2Y1 cell initially bathed in isosmotic CsCl
solution (300 mOsm). The cell was subsequently exposed to hyposmotic CsCl solution
(200 mOsm) and then hyposmotic CsCl solution plus 20 µM DCPIB. B) Cell currents
recorded while the cell was perfused with B) isosmotic CsCl, C) hyposmotic CsCl
solution and D) hyposmotic CsCl solution plus 20 µM DCPIB. Location of current traces
in the strip chart is similarly indicated. E) Current-voltage relationships for the three
current traces in B) through D) are displayed in black. The red plot represents the
difference in current between currents elicited under hyposmotic and hyposmotic +
DCPIB conditions.
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Figure 19 Rounded Parental cells exhibit a hyposmotically activated chloride
current that is inhibited by 20 µM DCPIB. A) Illustrated is a strip chart derived from
data obtained from a Parental cell initially bathed in isosmotic CsCl solution (300
mOsm). The cell was subsequently exposed to hyposmotic CsCl solution (200 mOsm)
and then hyposmotic CsCl solution plus 20 µM DCPIB. B) Cell currents recorded while
the cell was perfused with B) isosmotic CsCl, C) hyposmotic CsCl solution and D)
hyposmotic CsCl solution plus 20 µM DCPIB. Location of current traces in the strip
chart is similarly indicated. E) Current-voltage relationships for the three current traces in
B) through D) are displayed in black. The red plot represents the difference in current
between currents elicited under hyposmotic and hyposmotic + DCPIB conditions.
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Figure 20 DCPIB inhibits hyposmotic-induced current in rounded P2Y1 and
Parental cells in CsCl solution. A) Calculated whole cell conductance for P2Y1 (n=3)
and Parental (n=4) cells during perfusion with isosmotic CsCl, hyposmotic CsCl and
hyposmotic CsCl plus 20 µM DCPIB. B) Percent inhibition of hyposmotically activated
current, measured at +80 mV, by 20 µM DCPIB in P2Y1 (n=3) and Parental (n=4) cells.
Cells chosen for these experiments were identified as morphologically rounded. Cells
were then perfused in CsCl solution as described in the Materials and Methods section
and subjected to HOE for 5-10 min prior to addition of DCPIB. (* indicates p < 0.05)
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0.0430 nS/pF and 0.0725 ± 0.0068 nS/pF to 0.3493 ± 0.0179 nS/pF and 0.4782 ± 0.1102
nS/pF, respectively. Subsequent application of DCPIB during HOE caused a decrease in
conductance to 0.0883 ± 0.0296 nS/pF and 0.1393 ± 0.0251 nS/pF for round P2Y1 and
Parental cells, respectively. The hyposmotically activated current, measured at +80 mV,
was reduced by 103 ± 0.8% and 101 ± 5.6% for P2Y1 and Parental cells, respectively in
the presence of DCPIB (Figure 20B).

D. Exogenous ATP activates a DCPIB-insensitive chloride conductance
The effect of exogenous 1 mM ATP was analyzed under CsCl conditions in the
three cell types (Figures 21 – 24). Raw electrophysiological data showed an increase in
current amplitude in both P2Y1 and P2Y2 cells after exposure to 1 mM ATP (Figures 21
and 22). This current exhibited inward rectification, a reversal potential near 0 mV and
insensitivity to 20 µM DCPIB. Parental cells did not exhibit an increase in current
amplitude when exposed to exogenous ATP (Figure 23). 1 mM ATP caused normalized
whole-cell conductance increases from 0.1107 ± 0.0367 nS/pF to 0.1983 ± 0.0304 nS/pF
in P2Y1 cells and 0.0680 ± 0.0246 nS/pF to 0.1130 ± 0.0551 nS/pF in P2Y2 cells,
respectively, while Parental cells showed no increase (Figure 24). Initial experiments
using micromolar concentrations of exogenous ATP showed no change in current. Also,
P2Y1 cells (n=2) exposed to 500 µM ATP activated current of amplitude only 10% of the
currents elicited by 1 mM ATP (Data not shown).
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Figure 21 Exogenous ATP activates an inwardly rectified, DCPIB-insensitive
chloride current in P2Y1 receptor transfected cells. A) Illustrated is a strip chart
derived from data obtained from a P2Y1 cell initially bathed in isosmotic CsCl solution
(300 mOsm). The cell was subsequently exposed to 1 mM ATP (200 mOsm) and then 1
mM plus 20 µM DCPIB. Cell currents recorded while the cell was perfused with B)
isosmotic CsCl, C) 1 mM ATP in isosmotic CsCl and D) 1 mM ATP in isosmotic CsCl
solution plus 20 µM DCPIB. Location of current traces in the strip chart is similarly
indicated. C) Current-voltage relationships for the three current traces B) through D) are
displayed in black. The red plot represents the difference in currents elicited in the
presence and absence of ATP.
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Figure 22 Exogenous ATP activates an inwardly rectified, DCPIB-insensitive
chloride current in P2Y2 receptor transfected cells. A) Illustrated is a strip chart
derived from data obtained from a P2Y2 cell initially bathed in isosmotic CsCl solution
(300 mOsm). The cell was subsequently exposed to 1 mM ATP (200 mOsm) and then 1
mM plus 20 µM DCPIB. Cell currents recorded while the cell was perfused with B)
isosmotic CsCl, C) 1 mM ATP in isosmotic CsCl and D) 1 mM ATP in isosmotic CsCl
solution plus 20 µM DCPIB. Location of current traces in the strip chart is similarly
indicated. C) Current-voltage relationships for the three current traces B) through D) are
displayed in black. The red plot represents the difference in currents elicited in the
presence and absence of ATP.
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Figure 23 Exogenous ATP does not activate any chloride current in round Parental
cells. A) Illustrated is a strip chart of a Parental cell that is initially bathed in isosmotic
(300 mOsm) CsCl solution and is subsequently treated with 1 mM ATP. Cell currents
recorded while the cell is perfused with B) isosmotic CsCl solution and C) isosmotic
CsCl solution containing 1 mM ATP. Location of current traces in the strip chart is
similarly indicated. D) Current-voltage relationships for current traces in B and C.
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*

Figure 24 Exogenous ATP activates a chloride conductance in P2Y1 and P2Y2
receptor transfected cells, but not in Parental cells. A) Normalized conductance
during perfusion of isosmotic CsCl solution (Iso) and isosmotic CsCl solution plus 1 mM
ATP (ATP) in P2Y1 (n=3), P2Y2 (n=3) and Parental cells (n=3). Cells were then
perfused in CsCl solution as described in the Materials and Methods section and
subjected to 1 mM ATP for 5-10 min prior to addition of DCPIB. (* indicates p < 0.05)
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E. Western Blotting
Western blotting confirms P2Y1 and P2Y2 receptor expression in P2Y1 and
P2Y2 cells, but not in Parental cells. All cell lysates showed staining for Anti--actin
protein in both western blots shown (Figures 25 and 26). P2Y1 receptor bands in
the 90 kD range can be seen in both P2Y1 and P2Y2 cell lanes (Figure 25). P2Y2
receptor antibody generates similar results, with both P2Y1 and P2Y2 cells producing
bands above 90 kD (Figure 26). These bands are in the same kD range as described by
the antibody manufacturer (Alomone Labs) for human platelets. In an effort to inhibit
cross-reactivity between the two subtypes P2Y1 and P2Y2 receptor antibodies were preincubated with P2Y2 and P2Y1 peptide antigen, respectively, prior to use, as described in
the Materials and Methods section. Even under these circumstances bands were observed
in P2Y2 cell lysates when incubated with P2Y1 receptor antibody (Figures 25) and in
P2Y1 cell lysates when incubated with P2Y2 antibody (Figures 26).

F. Immunostaining
Initial experiments were performed under fixatives of 4, 2, 1 and 0.5%
paraformaldehyde solution. Similar intensities of receptor staining were found in each for
each fixing solution used (data not shown). Minimal fixation was desired, as the P2Y1
and P2Y2 receptor antibodies were derived from antigens in their native form, and thus
0.5% paraformaldehyde was used in subsequent studies.
All 1321N1 cell types were analyzed immunocytochemically for both P2Y1 and
P2Y2 receptor expression. Staining P2Y1 cells with anti-P2Y1 antibody yielded positive
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Figure 25 P2Y1 receptor expression in 1321N1 cell lines. Western blot probed with
anti-P2Y1 and anti--Actin as the primary antibodies. The anti-P2Y1 antibody was
incubated with P2Y2 peptide antigen prior to use as described in the Materials in
Methods section. Anti--Actin was used as a positive control.
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Figure 26 P2Y2 receptor expression in 1321N1 cell lines. Western blot probed with
anti-P2Y2 and anti--Actin as the primary antibodies. The anti-P2Y2 antibody was
incubated with P2Y1 control peptide prior to use as described in the Materials in Methods
section. Anti--Actin was used as a positive control.
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results (Figure 27A). However, anti-P2Y2 antibody also stained P2Y1 cells, albeit to a
lesser degree (Figure 27D). Pre-incubation, with P2Y1 control antigen as described in the
Materials and Methods, still yielded positive labeling with P2Y1 and P2Y2 receptor
antibody (Figure 27B and 27E, respectively). The level of staining when P2Y2 control
antigen was pre-incubated with P2Y2 receptor antibody was not visibly different than
when P2Y2 receptor antibody was used alone (Figure 27F). When no primary antibody
was used (the negative control) there was almost no staining of the P2Y1 cells (Figure
27C).
Similarly, P2Y2 cells were analyzed for both P2Y1 and P2Y2 receptor
expression. P2Y2 cells exhibited staining when exposed to anti-P2Y2 (Figure 28A) and
anti-P2Y1 receptor antibody (Figure 28D). Pre-incubation of either of these antibodies
with P2Y2 control antigen did not decrease the level of staining (Figures 28B and E).
Staining of P2Y2 cells with P2Y1 receptor antibody that was pre-incubated with P2Y1
control antigen did reduce staining to control levels (Figure 28F). When no primary
antibody was used, the negative control, there was almost no staining of the P2Y2 cells
(Figure 28C).
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Figure 27 Immunostaining of P2Y1 cells. A) P2Y1 cells stained using P2Y1 antibody,
B) P2Y1 antibody pre-absorbed with P2Y1 peptide antigen, C) no primary antibody, D)
P2Y2 antibody, E) P2Y2 antibody pre-absorbed with P2Y1 peptide antigen, F) and P2Y2
antibody pre-absorbed with P2Y2 peptide antigen.
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Figure 28 Immunostaining of P2Y2 cells. A) P2Y2 cells stained using P2Y2 antibody,
B) P2Y2 antibody pre-absorbed with P2Y2 peptide antigen, C) no primary antibody, D)
P2Y1 antibody, E) P2Y1 antibody pre-absorbed with P2Y2 peptide antigen, F) P2Y1
antibody pre-absorbed with P2Y1 peptide antigen.

74

V. Discussion

A. Results Summary and Conclusions
Initial recordings suggested cells perfused with PBS activated a chloride
conductance in response to HOE. Presence of ICl,swell was then confirmed in the CsCl
experiments. Not only did the hyposmotically activated current demonstrate
electrophysiological characteristics of ICl,swell, but it also was potently inhibited by
DCPIB, a selective ICl,swell blocker (Decher et al. 2001). Experiments on rounded cells
perfused with CsCl solution demonstrated that P2Y receptor expression is not necessary
for ICl,swell activation. ICl,swell was activated just as potently in round Parental cells as in the
P2Y1 or P2Y2 cells. A chloride current was activated by extracellular ATP, however it
did not demonstrate the electrophysiological characteristics typically ascribed to ICl,swell.
Previous literature describes an ATP activated chloride current with a pharmacological
profile similar to that of the P2Y1 receptor subtype (Darby et al. 2003). Our studies
indicate that both P2Y1and P2Y2 receptors are capable of activating the ATP induced
current. These results are based on the P2Y receptor expression reported from the
suppliers, however the immunocytochemical and western data in this study are
contradictory to those reports. It is clear that at least one of the receptor subtypes, P2Y1
or P2Y2, are responsible for the current activation, however, until receptor expression is
confirmed, it is unclear whether P2Y1, P2Y2 or both receptors are responsible.
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B. Electrophysiological Characteristics and TEA sensitivity of 1321N1
Human Astrocytoma Cells in Isosmotic PBS
Before analyzing the electrophysiology of the 1321N1 cells it is important to
recognize the conditions under which they were studied. All studies were performed in
vitro. Phosphate buffered saline (PBS) was used as an extracellular medium and I
designed the pipette solution to closely resemble physiological intracellular conditions.
All electrophysiological studies were performed using voltage clamp procedures. Such
recordings do not give exact resting membrane potentials; however, comparisons
between interpolated reversal potentials under different conditions can reveal changes in
relative conductances for the ions present.
A negative membrane potential is considered a defining characteristic of
astrocytes, as it is common to many astroglial sub-populations (Bordey & Sontheimer
2000), and is considered critical for the astrocyte function of potassium buffering
(Kuffler & Nicholls 1966, Orkand, Nichols & Kuffler 1966). All 1321N1 astrocytoma
cell subtypes; P2Y1, P2Y2 and Parental cells, had highly negative reversal potentials.
While this is not indicative of resting membrane potential it does imply a high relative
conductance for potassium which is true for most astrocytes. P2Y1 and P2Y2 cell types
had more negative reversal potentials than that of the Parental cell line. An increase in
potassium conductance across a membrane will cause membrane hyperpolarization, and
perhaps P2Y receptor expression facilitates increased potassium conductance under basal
conditions. Both P2Y1 and P2Y2 receptor activity leads to increases in intracellular
calcium (Burnstock 2007), which could activate BK channels. Exogenous ATP activation
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of BK channels has already been observed in other cell types (Hafting & Sand 2000,
Hafting et al. 2006).
Whole cell conductance of 1321N1 cells also was similar to that of cultured rat
astrocytes (Li, Liu & Olson 2002). Again the P2Y1 and PY2 cell types demonstrate
similar results that differ from those of the Parental cells. Parental cells generally
displayed higher whole cell conductance than the P2Y1 and P2Y2 cells.
Another defining electrophysiological characteristic of astroglial cells is the
presence of outward-rectifying potassium currents that are inhibited by 4-AP and TEA
(Bordey & Sontheimer 2000). Outward-rectifying currents were found consistently in the
P2Y1 and P2Y2 cells and 10 mM TEA was able to inhibit the majority of this current at
+80 mV. Parental cells did exhibit TEA-sensitive rectified currents, although not to the
same extent as P2Y1 and P2Y2 cells. Again, BK channel activity in the 1321N1 cells
could be tied to P2Y receptor function, and explain the lack of outward-rectifying current
in the Parental cells. The concentration of TEA needed to inhibit 50% of the outward
rectifying current was found to be 0.37 mM in P2Y1 cells, which is consistent with BK
channel inhibition described in previous literature (Catacuzzeno, Pisconti, Harper, Petris
& Franciolini 2000) as well as with other rectified K channels (Garcia-Diaz, Nagel &
Essig 1983).
TEA was used in this study to block the basal rectified current and thus reveal
other hyposmotically activated currents. While TEA effectively inhibits current measured
at positive potentials it has little effect on the currents evoked at the more negative
potentials near the reversal potential. The effect is that application of TEA did not have
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significant effect on normalized conductance or reversal potentials in any cell line, and
therefore it presumably did not inhibit any basal conductances.

C. Electrophysiological Response to Hyposmotic Exposure (HOE) in
PBS
The goal of the present study was to analyze the role of P2Y receptors in
hyposmotically activated currents; specifically ICl,swell. While recording cells perfused
with PBS, this was done in two ways. First, three subtypes of the 1321N1 human
astrocytoma cell line was used. As explained in Methods, one subtype expressed P2Y1
receptors, another P2Y1 and yet another lacked any P2Y receptor expression. By
comparing cells transfected with either P2Y1 or P2Y2 receptors to the P2Y lacking
phenotype, conclusions could be drawn as to their effect on hyposmotically activated
currents. The second way was the use of PPADS, which is a broad spectrum nucleotide
receptor blocker. PPADS is not specific for either of the subtypes used in this study, nor
is it specific for P2Y receptors in general (Burnstock 2007). However, since it had no
effect on Parental cells we can conclude that PPADS is specific for P2Y receptors in this
study.
The response of P2Y1 and P2Y2 cells to HOE in PBS was significantly different
than that of Parental cells. While all cell subtypes had increases in current amplitude and
conductance, they differed in PPADS sensitivity and change in reversal potential. As
stated above, Parental cells did not respond to PPADS. However, P2Y1 and P2Y2 cells
showed significant inhibition of hyposmotic-induced current by PPADS. Also, the
reversal potentials of P2Y1 and P2Y2 cells depolarize during HOE, while that of Parental
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cells does not. In experiments where PPADS is present P2Y1 and P2Y2 cells respond to
HOE by hyperpolarizing. This is similar to the response of Parental cells and thus,
confirms P2Y receptor activity is responsible for the depolarization during HOE.
The depolarizing change in reversal potential seen in P2Y1 and P2Y2 cells during
HOE could be interpreted as an increase in the conductance of chloride relative to that of
potassium. In the PBS experiments EK = -93.4 mV and ECl = -2.8 mV, thus an increase in
potassium conductance would result in hyperpolarization and an increase in chloride
conductance would produce depolarization. As discussed previously, a cell performing
RVD would expel osmolytes and only potassium and chloride have electrochemical
gradients directed out of the cell. If one was to assume that only potassium and chloride
conductances change during HOE, then calculations of potassium and chloride relative
conductance can be made using the Goldman-Hogkin-Katz equation. It would appear,
based on reversal potential depolarization, that P2Y1 and P2Y2 cells experience an
increase in the conductance of chloride relative to potassium during HOE from 0.0324
and 0.0374 to 0.0907 and 0.1730, respectively. Similar calculations for Parental cells
result in a decrease in the conductance of chloride relative to potassium during HOE from
0.0829 to 0.0689.

D. Electrophysiological Response to HOE in CsCl Solution
To better isolate ICl,swell in 1321N1 astrocytoma cells, equimolar concentrations of
CsCl in the pipette and bath solutions was used. The ICl,swell-inhibiting drug DCPIB was
also used in these CsCl experiments. Cesium was used in order to eliminate sodium and
potassium conductance similar to other protocols (Decher et al. 2001, Abdullaev et al.
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2006, Darby et al. 2003). Cesium is extremely impermeable to biological membranes and
therefore chloride currents can be isolated (Diamond & Wright 1969). DCPIB was also
used in these experiments as a selective ICl,swell inhibitor (Abdullaev et al. 2006, Decher et
al. 2001). For reasons described in the results, morphologically distinct populations of
cells were subjected to CsCl experiments. Recordings were made from morphologically
flat 1321N1 cells of all three subtypes and from morphologically round cells of the P2Y1
and Parental subtypes.
Hyposmotically activated ICl,swell was identified in round P2Y1 and Parental cells,
as well as flat P2Y1 and P2Y2 cells, but not in flat Parental cells. The hyposmotically
activated current exhibited all characteristics that define ICl,swell. In all cases DCPIB was
an effective inhibitor of the hyposmotically activated current and this DCPIB-sensitive
current displayed slight outward-rectification in all cell types. Time inactivation at
positive membrane potentials was present in all subtypes expressing the current. The
inactivation was less pronounced than in the PBS studies, however the holding potential
of 0 mV, instead of -70 mV, could have affected the channel kinetics. While prominent
time inactivation for ICl,swell is seen at a holding potential of -80 mV (Shuba et al. 2004) it
is much less pronounced when the holding potential is -50 mV (Decher et al. 2001) and 40 mV (Chiang, Luk & Wang 2004).
Morphologically flat Parental cells do not exhibit ICl,swell, while round Parental
cells do. The reason seems to be associated with the morphology of the Parental cells.
The vast majority of 1321N1 cells of all subtypes are flat. Rounded cells appear much
less often and appear to be either losing adhesion to the glass coverslip or are preparing to
divide. One reason for ICl,swell not presenting in flat Parental cells could be differential
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expression of membrane proteins during the cell cycle. A study in mouse liver cells also
only identified ICl,swell in rounded cells (Wondergem et al. 2001). In this study round cells
accounted for only 10% of the cell population, but were almost always found to be
mitotic. Conversely, flat cells were consistently found to be not mitotic. ICl,swell may not
be activated in flat Parental cells simply because it is not inserted into the membrane.

E. Exogenous ATP Activates a Chloride Current
Experiments involving exogenous ATP in isosmotic medium were performed to
determine whether P2Y receptors are sufficient to activate ICl,swell in 1321N1 cells. It is
important to note that during these experiments round Parental cells were targeted, in
order to be sure that channel expression was present. The concentration of ATP used in
these experiments was 1 mM, which is well above the normal range for P2Y activation
(Bours et al. 2006). Typical EC50s for P2Y1 are P2Y2 are around 21 µM and 1 M,
respectively (May, Weigl, Karel & Hohenegger 2006, Meshki, Tuluc, Bredetean, Ding &
Kunapuli 2003). A high concentration was used for two reasons. First, micromolar
concentrations of ATP, similar to those that activate P2Y receptors, were not successful
in activating any current. This could be attributed to ATP concentrations in the bulk
media being different from those in the pericellular space (Joseph et al. 2003), due to
multiple factors including ecto-ATPases that metabolize the ATP as it diffuses to the
membrane. Second, even when 1 mM ATP was applied to the bath solution during
Parental cell experiments there was no response. This indicates that the exogenous ATP
is acting on the P2Y1 and P2Y2 receptors of the corresponding cells, and not some other
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pathway. Current was also evoked in P2Y1 cells when a concentration of 500 µM ATP
was used, although to a much lesser degree than when 1 mM ATP was used.
Without HOE, exogenous ATP still can activate a chloride conductance via P2Y
receptor activation. Previous literature showed ADP is a more potent agonist than ATP
for activation of chloride current in rat astrocytes, and suggests the P2Y1 receptor
subtype as its mediator (Darby 2003). Currents are activated in both P2Y1 and P2Y2
cells when exposed to exogenous ATP in CsCl solution, however the currents display
characteristics dissimilar to that of ICl,swell. The ATP activated current lacks inactivation at
depolarizing potentials and, more importantly, displays inward rectification. These
characteristics were consistent in all P2Y1 and P2Y2 cells studied and indicate ATP
activates a different current than ICl,swell. The ATP-induced current has a similar currentvoltage relationship to that of ClC-2 (Duann et al. 2000). Although ClC-2 has been
shown to be dependent on intracellular ATP, no evidence exists for its activation by
extracellular ATP (Roman et al. 2001). Another chloride current, aptly termed ICl,ATP
responds to ATP, but does not demonstrate inward rectification (Yamamoto-Mizuma,
Wang & Joseph 2004).

F. P2Y Receptor Expression in P2Y1, P2Y2 and Parental Cell Subtypes
Great effort was made to identify P2Y receptor expression in the three 1321N1
cell subtypes. Both western blotting and immunostaining were employed using
polyclonal antibodies for P2Y1 and P2Y2 receptors. Commercially purchased antibodies
were raised in rabbit from peptide antigens from the third intracellular loop, between
transmembrane domains 5 and 6, of their respective receptors. Because antibodies for
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P2Y1 and P2Y2 receptors were polyclonal and raised from similar domains there was a
fear of cross-reactivity. To account for this, P2Y receptor antibodies were pre-incubated
with the peptide antigen of the other P2Y receptor. This method was used in both western
blotting and in immunostaining.
Western and immunoblotting could not distinguish P2Y1 from P2Y2 receptor
expression, however it did clearly show that Parental cells do not express either P2Y1 or
P2Y2 receptors. In western blots, Parental cell lysates demonstrated bands for β-Actin but
not for either P2Y1 or P2Y2 receptors. Parental cells were consistently negative when
immunostained with either primary antibody. These results validate that the
electrophysiological difference between the receptor and the Parental subtypes can be
attributed to the P2Y receptor expression.
Western blots were positive for both receptor proteins in P2Y1 and P2Y2 cells.
This was in spite of the fact that each antibody was pre-incubated with peptide antigen
from the other receptor as described above. Immunostaining also revealed both P2Y1 and
P2Y2 receptor expression in P2Y1 and P2Y2 cells. P2Y1 and P2Y2 cells that were not
incubated with primary antibody demonstrated significantly less staining. Both of these
facts indicate that the antibodies in question were staining for the intended receptors.
However, pre-incubation of P2Y1 antibody with P2Y1 antigen and P2Y2 antibody with
P2Y2 antigen during immunostaining did not significantly modify labeling of the
receptors in both cell types. This implies that the control antigens were ineffective in
absorbing the active antibodies and cross-reactivity could still be a problem. Further
experimentation involving calcium mobilization in response to specific agonists should
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be performed in order to clarify if P2Y1 and P2Y2 receptor expression is functional in
the corresponding cell types.

G. The Role of P2Y Nucleotide Receptors in ICl,swell Activation
Previous literature has made the claim that exogenous ATP plays a role in ICl,swell
activation via P2Y receptors, although the exact nature of this role has been debated. One
set of studies argues that exogenous ATP is not necessary for ICl,swell activity, but
potentiates the response when applied in addition to HOE (Mongin & Kimelberg 2003).
These studies measured radiolabeled aspartate concentrations in perfusate from cells
during HOE exposure in the presence and absence of ATP. Aspartate is known to be
permeable to VRAC, the channel thought to be responsible for ICl,swell. Micromolar
amounts of ATP were able to greatly increase aspartate release from cells during HOE,
however exogenous ATP in the absence of HOE was unable to initiate aspartate release.
Another study reported that exogenous ATP, released during cell swelling, is required for
ICl,swell activation (Darby et al. 2003). These experiments employed voltage clamp
techniques to record chloride current from cultured rat astrocytes in a fashion similar to
the present study. The hyposmotically activated chloride current was inhibited by
apyrase, as well as a number of nucleotide receptor blockers. Also, application of
exogenous ATP in the millimolar range activated a chloride current. However, neither
apyrase nor the P2Y receptor blockers were able to block the entire hyposmotic current.
Neither study managed to directly answer the question of whether nucleotide signaling
alone is sufficient to activate ICl,swell.
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The goal of this study was to determine if P2Y signaling is necessary and
sufficient for ICl,swell activation. When exposed to hyposmotic medium round Parental
cells activate ICl,swell, demonstrating that P2Y receptor expression is not necessary. The
lack of ICl,swell during HOE in flat Parental cells could demonstrate lack of expression of
VRACs in the membrane, or that flat cells have a different cytoskeleton architecture that
prevents significant swelling. It should also be pointed out that Parental cells in the PBS
studies were also morphologically flat, which could explain why an increase in chloride
conductance was not seen.

H. Unanswered Questions and Future Directions
As MacVicar and colleagues stated (in reply to Mongin & Kimelberg 2003),
chloride channel activation is a complex phenomenon in astrocytes, and our findings are
no different. Round Parental cells can clearly activate ICl,swell during HOE. Why are flat
P2Y1 and P2Y2 cells able to activate ICl,swell during HOE and flat Parental cells are not?
There may be multiple mechanisms for gating or membrane insertion of VRAC. Perhaps
elevated intracellular calcium gates VRAC activation. P2Y receptor activation is able to
gate VRAC by such a mechanism, as was seen in the flat P2Y1 and P2Y2 cells. Gating
could also be accomplished by another mechanism related to the cell cycle (Wondergem
et al. 2001). Whether the round Parental cells are in a different stage of the cell cycle than
their flat counterparts is speculation at this point, however it would explain why round
Parental cells are able to activate VRAC and flat Parental are not. Another question is
whether exogenous ATP is activating ICl,swell or another population of chloride channels?
The present voltage clamp experiments depicts the ATP activated current as having a
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different electrophysiological profile than that of ICl,swell. This suggests that the current
activated by 1 mM exogenous ATP is probably mediated by a channel other than VRAC.
It has been shown that many chloride channels are activated during HOE (Zhang & Jacob
1997). Considering ATP has been shown to reach P2Y activating concentrations in the
pericellular space of astrocytes during HOE (Okada et al. 2006) it is not surprising that a
portion of the chloride current evoked during HOE is sensitive to nucleotide blockers
(Darby et al. 2003).
Future studies are needed to determine how P2Y receptors are involved in gating
ICl,swell and what channel mediates the ATP-activated current. Studies in CsCl using
PPADS and other nucleotide receptor pathway antagonists could answer the question of
how P2Y receptors affect gating or membrane insertion of ICl,swell. Electrophysiological
and pharmacological characterization of the ATP-activated channel could lead to its
identification. Finally, to reach beyond academic questions and into medical applications,
in vivo research is needed to identify if ICl,swell plays a role in the physiological response
to brain edema. If this role is better understood, then activity of ICl,swell could be modified
in order to prevent neural injury during stroke and other brain traumas.
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